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1ABSTRACT
A functional placenta is an absolute requirement for normal embryonic, fetal
and post-natal development.  During the first trimester of pregnancy,
trophoblast expands rapidly, invades the uterine wall and contributes to
placental formation.  Development of the vascular bed facilitates the
absorptive, excretory and respiratory functions of the human placenta.
Multiple cell types are present at sites of placental vascular development,
including hematopoietic stem cells, endothelial cells, trophoblast and placental
stromal fibroblasts.  Polarographic measurements made in utero have
provided precise information regarding local oxygen tensions (pO2) at the
feto-maternal interface during various stages of development.  Using these
values as a guide, a novel protocol is described that allows simulation of in
utero oxygen environments with real-time monitoring of oxygen levels.  The
impact of oxygen on hematopoietic stem/progenitor cell (HSPC) proliferation,
cell cycle status, apoptosis and differentiation was investigated.  We
demonstrate that the low oxygen environment of the developing placenta may
help maintain the HSPC stem cell phenotype, while simultaneously inducing
the differentiation of monocytes.  Locally derived factors also have effects on
HSPC in the placental microenvironment.  The chemokine SDF-1α / CXCL12
is commonly found in low oxygen environments and is known to effect
CXCR4-expressing hematopoietic cells.  Results from this investigation
indicate that SDF-1α is expressed in chorionic villi throughout gestation.
Furthermore, isolated villous stroma-enriched cell fractions secreted SDF-1α
in vitro.  HSPC expression of CXCR4 increased during coculture with
placental cells in low oxygen.  Interactions of placental-derived SDF-1α with
CXCR4 effects HSPC migration, transendothelial migration and adhesion of
HSPC.  Results indicate the involvement of SDF-1α in attracting CXCR4-
expressing HSPC to areas of placental vascular development.
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71 INTRODUCTION
Hypoxia is a commonly used term in medicine, especially in
reproductive medicine and biology.  But, what is hypoxia?  Hypoxia can be
defined as a pathological or abnormally low level of oxygen at a given site at a
defined point in time.  This leads logically to the term used to represent
physiologically relevant oxygen levels - normoxia.  A subtlety quite often
overlooked is what is normoxia in the system of interest.  In the field of cell
biology, this important question has been seemingly ignored.  Quite often in
vivo oxygen levels in the tissue of interest vary markedly from oxygen levels
encountered in the incubator.  Ambient oxygen during normal tissue culture is
convenient and, moreover, mimicking in vivo oxygen concentration during in
vitro culture can be time-consuming, expensive and fraught with multiple
problems.
The terms hyperoxia or superoxia are used to describe pathologically
high oxygen levels.  The mean partial pressure of oxygen (pO2) in oxygen-rich
arterial blood is equivalent to 95 mmHg, thus representing an oxygen
concentration of approximately 12% with various local and regional variations
(Balin et al., 1984).  Healthy blood circulation delivers a mean pO2 of 32
mmHg to tissues, representing an oxygen concentration of approximately 4%.
Ambient atmospheres during traditional cell culture contain around 21% O2
and, thus, represent clearly hyperoxic conditions.  The detrimental effects of
oxygen on tissues and cells have been extensively studied.
Physiological oxygen concentrations change throughout pregnancy.
The human placenta, for example, encounters different oxygen tensions at
specific periods of development.  The placenta facilitates these changes and
adapts accordingly in order to meet the needs of the developing fetus.  At
implantation, the fetal derived placenta becomes the primary organ
responsible for the transfer of gases from maternal blood to the embryo.
Obviously, oxygen levels must be tightly regulated to ensure normal
placentogenesis and embryogenesis.  Alterations in oxygen tensions during
pregnancy have been linked to different pregnancy related disorders (Mayhew
et al., 2004).
8Development of the placenta is a requirement for development of a
healthy, term baby.  Cell differentiation, trophoblast invasion and vascular
development are part of this tightly regulated process.  Aberrant development
of the placenta and associated vascular tree has been linked to early
pregnancy losses and different pregnancy-related pathologies, such as
preeclampsia and intrauterine growth retardation (IUGR).  Epidemiological
studies point out an increased risk for hypertension, diabetes and
cardiovascular diseases in adulthood in association with IUGR (Barker et al.,
1990).  Oddly enough, the precise mechanisms of early placental
vasculogenesis and angiogenesis remain unclear.
1.1 Implantation and the Blastocyst
Early embryological investigations have demonstrated that, after
fertilisation, successive cell cleavages result in two-cell, four-cell and eight-cell
embryos (Drews, U. Taschenatlas der Embryologie 1993).  At the eight-cell
stage, compaction of the embryo creates the morula.  A blastocyst arises
following further cell divisions.  The blastocyst is a multicellular stage
consisting of an inner cell mass (ICM) encased in a shell of specialised cells
called trophectoderm.  The ICM will eventually develop into an embryo, while
trophectoderm develops into a placenta.  In the oxygen-poor environment of
the female genital tract, a preimplantation blastocyst spends its first week
travelling from the site of conception to the maternal endometrium.  The
process of implantation commences six to seven days post conception (6-7
dpc).
 Successful blastocyst implantation depends on synchronisation of a
complex series of molecular and cellular events in the embryo and uterus.
Apposition, the first stage of implantation, involves the initial, unstable
adhesion of the blastocyst to the uterine wall.  Stable adhesion, revealed by
an increased contact between the uterine epithelium and trophectodermal
layer of the blastocyst, represents the next step during implantation (Figure 1).
The blastocyst then invades the uterine endometrium, creating a site where
development can proceed.  In preparation for implantation, the maternal
endometrium undergoes morphological changes, known as decidualization.
9Decidualization occurs when endometrial stromal cells proliferate and
differentiate into a distinct cell type, called decidual cells.  Maternal spiral
arteries present in the decidua also prepare for the embryo’s arrival.  Within
the uterine wall, ICM initiates a period of extensive growth and differentiation
known as embryogenesis.  Simultaneously, trophectoderm grows and
differentiates, thereby forming the extra-embryonic organ known as placenta.
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Figure 1. Human blastocyst implantation and early
placentation. Implantation involves stable adhesion of blastocyst to
uterine epithelium (A).  As the blastocyst transgresses the epithelial
layer, trophectodermal cells proliferate and invade the uterine
decidua (B). The process of embryogenesis results in formation of
the embryonic disc. Extra-embryonic yolk sac (YS) also forms
during this time. Further invasion into decidua results in total
blastocyst encapsulation (C). The chorion arises through
differentiation of trophectodermal cells and will eventually consist of
cytotrophoblast and syncytiotrophoblast. In humans, fusion of the
chorion and allantois results in formation of a chorioallantoic
placenta. Figure modified from Moore, 1988.
1.2 The Human Placenta
Placentogenesis initiates as the blastocyst makes contact with the
epithelial lining of the uterus.  It results from rapid proliferation and
differentiation of trophectodermal and adjacent mesenchymal cells of extra-
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embryonic origin.  The human placenta functions during gestation as a semi-
permeable barrier and is responsible for the exchange of gases, nutrients and
wastes between the fetus and its mother.
1.2.1 Placental development and structure
The placenta is a large, multifunctional organ (Figure 2).  As an
endocrine organ, the placenta produces a multitude of hormones, growth
factors and chemokines.  These factors activate autocrine and/or paracrine
pathways, thus regulating cellular functions at the feto-maternal interface
(Lala and Hamilton, 1996).  In addition to its endocrine role, the placenta
carries out many of the fetal functions, including feeding, excretion and
respiration (Zygmunt, M. in Klinische Pathophysiologe 2006).  Furthermore,
placenta acts as a protective barrier from potentially harmful substances
found in the maternal microenvironment (Lala et al., 1983).
Placentas can be classified according to the extent of their
invasiveness into three main types: noninvasive epitheliochorial, moderately
invasive endotheliochorial, and highly invasive hemochorial (Benirschke and
Kaufmann, 1990).  Human placenta is hemochorial.  This high degree of
invasiveness is necessary for maintenance of the embryonic implantation
site and subsequent penetration of maternal blood vessels.  Concomitant
with trophoblast invasion, placental cells are proliferating thereby forming a
large cell population comprised of many cell types, including trophoblasts,
fibroblasts, vascular endothelium and immune cells.  At term (∼40 weeks
post conception (wpc)), placenta is the largest endocrine organ weighing
approximately 600 grams (Boyd and Hamilton, 1970).
Trophoblast cells of the blastocyst proliferate rapidly throughout the first
trimester.  During the first week of implantation, the placenta consists of an
inner layer of cytotrophoblast surrounded by a multinucleate
syncytiotrophoblast layer, derived by fusion of mononucleate
cytotrophoblasts (Figure 1).  Together, they form a sponge-like network
outlining spaces containing tissue fluid called lacunae.  Soon, lacunae fill
with maternal blood owing to the destruction of maternal capillaries and
arterioles within the endometrium by invasive trophoblast cells.  As these
blood-filled sinusoids expand, maternal blood surrounds finger-like
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projections comprised of cytotrophoblast cells and the multinucleate
syncytiotrophoblast.  These structures are termed chorionic villi and
represent the basic structural unit of the placenta (Moore, 1988).
Figure 2. Schematic representation of human placenta at mid-
gestation. Invasion of trophoblast cells opens up the endometrial
arteries and the placenta becomes bathed in maternal blood. The
placenta assumes a respiratory, absorptive and excretory function
and formation of the placental vascular tree facilitates the transfer
of nutrients, gases and wastes between the developing fetus and
mother. Umbilical cord, containing the umbilical vein and umbilical
arteries, connects placenta to the fetus. Figure reproduced Ross et
al., 1995.
Chorionic villi can be categorised according to structure.  Primary
chorionic villi consist of two layers - a cytotrophoblast layer surrounded by
syncytiotrophoblast.  As development proceeds, secondary chorionic villi are
formed when extra-embryonic mesoderm cells infiltrate the villous core.  The
lack of vascular structures within primary and secondary chorionic villi and
absence of maternal blood flow suggests that early placentogenesis occurs
in an oxygen-poor environment.  As the villous core becomes vascularised,
the resultant structures are called tertiary villi.  Fully functional tertiary
chorionic villi can assume two separate structures, each illustrating distinct
differentiation pathways of the villous cytotrophoblast.  Floating villi do not
attach to decidua, but instead project directly into maternal sinusoids where
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they are bathed in oxygen-rich maternal blood.  Surrounded by a
multinucleate syncytiotrophoblast layer, floating villi maintain a primarily
absorptive and endocrine role.  On the other hand, anchoring villi attach the
placenta to the pregnant uterus.  These chorionic villi contain highly
proliferative villous cytotrophoblast cells at the base that break through the
syncytium and form cell columns.  A subset of cytotrophoblast cells from the
anchoring villi, called extravillous trophoblast (EVT), migrate and invade the
uterine decidua (Aplin, 1991; Graham and Lala, 1992).  Some EVT form an
organised cell layer called the cytotrophoblastic shell, while others remain
dispersed in the decidua as interstitial trophoblasts. Yet another subset of
EVT invades and modifies maternal spiral arteries.  As EVT invade the walls
of the uterine spiral arteries, the vessels are adapted into bore conduits
capable of delivering an increased supply of oxygen-rich maternal blood to
the placenta (Zhou et al., 1997).
1.2.2 Oxygen levels in the developing placenta
From implantation and throughout the first trimester, both embryo and
placenta develop in an oxygen-poor environment.  During the first ten to
twelve weeks of gestation (10-12 wpc), the openings of uteroplacental
arteries to the intervillous spaces contain plugs of trophoblast cells.  After 10
wpc, trophoblastic plugs loosen and blood begins to seep into this space;
after 12 wpc, oxygen-rich maternal blood bathes the placenta and oxygen
levels begin to rise.  This implies that the first trimester human placenta is
not truly hemochorial - that is, chorionic cells do not contact maternal blood -
until the end of the first trimester (Jauniaux et al., 2001).
Early studies attempted to measure oxygen levels in the feto-placental
unit using a variety of techniques.  Most techniques involved the use of in
vitro gas measurements representing partial pressures of oxygen (pO2).
These measurements were often inconsistent.  Laboratory gas
measurements are fraught with a variety of pitfalls, with the fact that ambient
oxygen contains approximately 21% O2 topping the list.  Other difficulties
associated with laboratory measurements of in vitro pO2 include: the
presence of air bubbles in the sample, diffusion of gases through plastic and
changes associated with measuring samples at room temperature.  More
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recently, Jauniaux and colleagues have used multiparametic sensor probes
inserted under ultrasound guidance into the pregnant human uterus
(Rodesch et al., 1992; Jauniaux et al., 1999; Jauniaux et al., 2001).  This
technique has led to more accurate measurements of oxygen concentrations
and acid-base gradients present at the feto-maternal interface during the
course of gestation.  Polarographic probes have likewise been utilised to
assess placental and endometrial pO2 during the first trimester of pregnancy
(Rodesch et al., 1992).
In vivo gas measurements have provided further evidence that early
human placenta is not in direct contact with maternal blood.  At 8-10 wpc,
pO2 in the feto-placental unit was measured at 17.9 ± 6.9 mmHg and a
marked pO2 gradient between the decidua and placental tissue was noted.
In fact, the mean pO2 of the placenta was approximately three times lower
than that of the underlying decidua (Jauniaux et al., 2001).  After 11 wpc,
placental pO2 increased more than two-fold.  By the 12 wpc, placental pO2
levels were similar to those found in the surrounding decidua, with a mean
pO2 equivalent to 56.2 ± 3.2 mmHg (Rodesch et al., 1992).  This increase in
oxygen levels corresponds to the establishment of continuous maternal
blood flow to the placenta.  Maximum oxygen tensions (65.0 ± 3.4 mmHg)
were measured in human placentas approximately 16 wpc.  After this
maximum is reached, oxygen levels in the placenta decline until term, most
likely representing the increased oxygen consumption of the feto-placental
unit (Jauniaux et al., 1999).
1.2.3 Placental vasculogenesis and angiogenesis
The processes regulating vascular development occur, most often, in
oxygen-low environments (Coultas et al., 2005).  In fact, formation of a new
blood vessel de novo or through the extension of pre-existing vessels has
been shown to be tightly regulated by oxygen.  The human placenta is no
exception, where formation of the placental vascular tree occurs entirely in a
low oxygen environment through the processes of vasculogenesis and
angiogenesis.
Vasculogenesis involves de novo formation of blood vessels from
precursor cells whilst angiogenesis involves creation of new vessels from
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pre-existing vessels.  Migration and differentiation of endothelial progenitor
cells (EPC) to form interconnecting capillaries occurs during the process of
vasculogenesis.  Communication between endoderm and mesoderm
appears to be important during vasculogenesis as well as during subsequent
growth and stabilisation of blood vessels.  Interestingly, the close spatial
proximity of hematopoiesis and vascular development has led to the
suggestion of a multipotent cell, the hemangioblast, with the inherent
capacity for both vascular and hematopoietic developmental pathways (Park
et al., 2005).  At the second week of gestation (13-15 dpc), multipotent
hemangioblasts emerge at extra-embryonic sites in blood islands of the
developing yolk sac.  Both primitive hematopoietic and endothelial cells are
found in blood islands.  Early hematopoietic and vascular cells are also
found in temporal and spatial proximity during placental development.  The
earliest stages of placental vasculogenesis can be seen approximately ten
days later (23-26 dpc).  Angiogenesis occurs next during placental
development as early blood vessels expand and adapt to meet the needs of
the embryo.
Improper development of the placental vascular tree has been
implicated in a number of devastating pregnancy-related complications.  For
example, preeclampsia is a potentially lethal complication of the second half
of pregnancy, labour or early period after delivery.  It affects approximately
3% of women and is characterised by hypertension, abnormal levels of
protein in urine and other systematic disturbances (Redman and Sargent,
2005).  Oxygen levels in the feto-maternal unit play a key role (Kuenzel and
Kirschbaum, 1992).  Preeclampsia frequently results from the presence of a
hypoxic placenta (Burton and Jauniaux, 2004).  Early on in pregnancy, poor
placental development leads to the appearance of maternal symptoms such
as hypertension and proteinuria.  The cellular and molecular mechanisms
regulating early placental development remain largely unclear.
1.3 Hematopoietic Stem Cells (HSC)
At the earliest stages of development, the preimplantation blastocyst
has absolutely no access to the oxygenated maternal blood supply.  In the
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multicellular blastocyst, the oxygen concentration deep within the ICM is
accordingly low.  This environment is home to multipotent cells capable of
creating an entire organism and blastocysts have been used in the derivation
of a number of human stem cells, including embryonic stem cells (ESC) and
trophoblast stem cells (TSC).
Stem cells are defined as cells capable of unlimited self-renewal and
the ability to give rise to multiple cell types.  These parameters are subject to
wide interpretation and depend to some degree on whether the cells are
present in their normal environment, residing in the so-called stem cell niche,
or in an experimental setting.  Pluripotent ESC, derived from the ICM, have
unlimited self-renewal properties and give rise to all embryonic tissue types in
vitro (Thomson et al., 1998; Reubinoff et al., 2000).  However, unlimited self-
renewal is not a property of cells of the ICM in situ, where they differentiate
into various tissues thereby losing the pluripotent ESC phenotype.  Multipotent
adult stem cells, on the other hand, give rise to a wide range of progenitor and
mature cells.  Many multipotent adult stem cells have unlimited self-renewal -
their differentiated progeny have limited self-renewal.  Hematopoietic stem
cells (HSC) are prototypical multipotent adult stem cells.
Adult stem cells, including HSC, by definition must have both a
tremendous capacity for self-renewal and a large differentiation range.  In the
absence of overt injury, bone marrow-derived HSC maintain the total pool of
HSC at a roughly constant level through asynchronous divisions (Cheshier et
al., 1999).  HSC also give rise to progenitor cells, in this report referred to as
hematopoietic stem / progenitor cells (HSPC).  Differentiated progeny of
HSPC include lineage-restricted progenitor cells.  Further differentiation
produces all lineages of the hematopoietic system, including monocytes,
granulocytes, megakaryocytes and erythrocytes.  The cellular signals that
influence the choice between self-renewal and differentiation are incompletely
defined.  Therefore, a long-term goal is precise knowledge about the
molecular mechanisms associated with HSC development and lineage
decisions.  Complicating the matter is that in vitro proliferation of HSC
inevitably leads to hematopoietic differentiation or death with a subsequent
loss of multipotent, self-renewing stem cells (Kondo et al., 2003).
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1.3.1 Hematopoiesis and lineage commitment
The highly orchestrated process of blood cell production is
termed hematopoiesis.  During the life of an organism, HSC generate
multiple blood cell lineages through a successive series of intermediate
progenitors, which involves the progressive loss of developmental potential
to other lineages.
Definitive HSC are functionally defined by their capacity for extensive
self-renewal.  Also called long-term (LT)-HSC, a single cell can give rise to
multilineage reconstitution in irradiated patients (Smith et al., 1991).
Maturation of LT-HSC leads to a multipotent stem / progenitor cell
population (i.e. HSPC) with a more limited self-renewal capacity.  The
earliest lineage-potential decision that HSPC must make is whether to
become a lymphoid or myeloid cell.  This first differentiation decision
produces lineage restricted progenitor cells called common myeloid
progenitors (CMP) or common lymphoid progenitors (CLP).  The
differentiated progeny downstream of CMP and CLP are even more mature
progenitors further restricted in the number and type of lineages they can
generate.  CMP give rise to myeloid cell lineages, including monocytes,
granulocytes, megakaryocytes and erythrocytes, while CLP produce cells of
lymphoid lineages, such as B cells, T cells and natural killer (NK) cells.
Terminally differentiated cells, such as erythrocytes, are ultimately produced.
They have lost all self-renewal capacity and eventually undergo apoptosis.
Traditional knowledge has suggested that this step-wise developmental
process is linear in the sense that once a cell has made a developmental
choice it is permanent (Figure 3).  Recent interest in stem cell research has
reopened the debate as to whether the process of hematopoiesis is more
plastic than traditionally considered.
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Figure 3. Linear representation of hematopoiesis.  Long-term
hematopoietic stem cells (LT-HSC) are the most primitive HSC.
Proliferation and differentiation produces a population of
hematopoietic stem / progenitor cells (HSPC). The first lineage
decisions produces common myeloid progenitors (CMP) and
common lymphoid progenitors (CLP); subsequent differentiation of
HSPC results in more restricted progenitors (MEP, GMP). Further
differentiation produces the entire repertoire of hematopoietic cells
required during life.
1.3.2 HSC development
The primary sites of hematopoiesis change in a temporally and
spatially co-ordinated fashion during human development (Figure 4).  A
close association of endoderm with mesoderm appears to be a typical tissue
make-up at sites of hematopoiesis.  Until establishment of definitive
hematopoiesis in the bone marrow, microenvironmental cues regulate HSC
self-renewal and differentiation.  In stem cell biology, the local
microenvironment is also known as the niche.  Locally derived signals are
involved in the formation and maintenance of various HSC niches.
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Figure 4. Developmental sites of human hematopoiesis. At
implantation, primitive hematopoiesis begins in the yolk sac.
Primitive HSC can later be found in the aorta-gonads-mesonephros
(AGM) region. Definitive hematopoiesis sites are transient during
development. Traditional knowledge states that the fetal liver is
responsible for seeding the final HSC niche – bone marrow. It
remains unclear whether the placental HSPC niche remains
throughout gestation. Figure adapted from Mikkola et al., 2005.
Primitive hematopoiesis in the blood islands of the extra-embryonic
yolk sac creates the earliest hematopoietic cells of the developing
mammalian embryo (Figure 5).  Yolk sac hematopoiesis is biased towards
erythropoiesis with primitive erythrocytes indispensable to oxygenation of
the developing embryo.  Development of a functional yolk sac occurs during
implantation of the human blastocyst at approximately 13-15 dpc (Palis and
Yoder, 2001).  The cellular components of the blood island niche consist
originally of undifferentiated mesodermal progenitor cells (i.e.
hemangioblasts) and stromal cells apposed to visceral endoderm (Tavian
and Peault, 2005).  By the time that the secondary yolk sac is formed,
mesodermal cells come in contact with cells of the chorion.  The first
appearance of blood islands is illustrated by hematopoietic and endothelial
cell aggregates in the yolk sac stroma.  Yolk sac-derived progenitors
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contribute to a transient wave of hematopoiesis, while other sites contribute
to the hematopoietic needs of the growing embryo.
A.
endodermprimary yolk sac placenta mesoderm
B.
secondary yolk sac
embryonic disc
mesoderm
endoderm
Figure 5. Human yolk sac development. Formation of primary
yolk sac occurs during implantation when extra-embryonic
mesodermal cells come in direct contact with placental cells (A).
Extra-embryonic endoderm is directly apposed to mesoderm.
Secondary yolk sac appears during embryonic disc formation (B). A
layer of extra-embryonic mesoderm surrounds the chorion while
extra-embryonic endoderm and mesoderm remain in contact.
Figure reproduced from Palis and Yoder, 2005.
The next wave of hematopoiesis can be seen during the second month
of gestation when clusters of round cells expressing several markers of HSC
are observed within major intra-embryonic and extra-embryonic arteries
(Labastie et al., 1998).  At 27 dpc, cells within the aorta-gonads-
mesonephros (AGM) region adhere firmly to the ventral endothelium of the
embryonic aorta; these HSC proliferate rapidly and totally disappear by 40
dpc (Tavian et al., 1999).  It was observed that expression of the
extracellular protein CD34 accompanies early ontogeny of both the
hematopoietic and vascular systems.  AGM is a unique example of a
localised territory where multipotent HSC transiently emerge and proliferate.
CD34-positive (CD34+) cells isolated from this region generated both
lymphoid and myeloid cells, demonstrating the presence of progenitor (e.g.
HSPC, CMP, CLP) cells (Tavian et al., 2001).  As HSC in the AGM region
are only found during a short developmental window and their number is low
at any given time, questions have been raised whether the AGM region
alone can supply all HSC in the expanding pool.  In humans, a detailed
analysis of this region has been hampered with the obvious scarcity of
healthy tissue.  Nonetheless, Tavian and colleagues (2001) have stated that
ventral periaortic mesenchymal cells produce the chemoattractant, stromal-
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derived factor (SDF)-1α, although original results remain until now
unpublished.  The early involvement of cytokines in creation of the AGM
niche remains an interesting field of investigation.
Following primitive hematopoiesis in the yolk sac and a transient stage
in the AGM, definitive hematopoiesis commences in the liver.  Definitive
hematopoiesis results in production of all hematopoietic lineages.  At
approximately 22 dpc, the fetal liver can be identified in the developing
human embryo.  HSC can be found in the developing liver around 30 dpc.
Fetal liver cannot generate its own hematopoietic cells but instead needs to
be seeded from another HSC source.  Seeding of liver by HSC appears to
involve the early fetal circulation.  The first vascular connection to fetal liver
comes from the yolk sac through the vitelline veins.   The second vascular
connection is the umbilical vein from the developing placenta. The
appearance of progenitor cells (HSPC), as identified by expression of CD34,
in embryonic liver and long-term in vitro culture of liver cells suggests the
multipotentiality of liver hematopoiesis (Labastie et al., 1998).  The
hematopoietic profile of fetal liver changes during gestation with its
repertoire increasing from erythroid differentiation to include megakaryocytic,
myeloid, and B lymphoid development.  Importantly, fetal liver provides a
supportive niche for the growing pool of HSC before they move to their adult
home.
Bone marrow is the last blood-forming tissue that develops in
ontogeny, when hematopoiesis is extinct in the yolk sac and transiently
active in the liver.  Bone marrow hematopoiesis begins around 11 wpc after
HSC originating in the fetal liver begin to seed developing long bones.
Within specialised niches, bone marrow supports self-renewal of the HSC
pool and, at the same time, differentiation of progenitor cells to the various
hematopoietic lineages.  Formation of the bone marrow niche involves the
precise interplay between microenvironmental cues, such as oxygen level,
cytokine production, and heterotypic cell-cell adhesions.  The chemokine
SDF-1α seems to play a key role in HSC homing to their bone marrow
niche.  Using transgenic technology, Nagasawa and colleagues (1996) have
demonstrated that mice lacking both copies of the SDF-1α gene had
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defective bone marrow hematopoiesis and died perinatally.  HSPC in mutant
embryos were reduced in bone marrow, demonstrating the importance of
chemokines in creating a supportive HSPC niche.
1.3.3 Hematopoiesis in the placenta
Recent investigations have demonstrated the presence of a third pre-
hepatic HSC niche.  One common characteristic of sites of hematopoiesis is
that the generation of hematopoietic cells coincides with that of endothelial
cells.  As previously mentioned, the human placenta is one of the earliest
vascularised organs during development and hematopoietic cells have been
found within early chorionic villi.  In fact, the presence of cells appearing
microscopically to be hematopoietic in origin, have been described for quite
some time.  Transmission electron microscopy demonstrated the presence
of hematopoietic cells in first trimester placental tissue (Demir et al., 1989).
Furthermore, the name hemangioblastic cord, which has been used to
describe the early site of placental vasculogenesis, suggests the
multipotentiality of stem cells found in placenta.
Placenta may serve as another supportive niche that facilitates
maturation and expansion of HSC.  In vivo studies in mice have shown that
mid-gestation placenta harbours a large pool of multipotent HSC.  Placental
HSC have the capacity to self-renew and repopulate the entire
hematopoietic system (Ottersbach and Dzierzak, 2005; Gekas et al., 2005).
Interestingly, the placental HSC pool is transient and diminishes while the
fetal liver HSC reservoir expands.  As the placenta is located directly
upstream of liver in fetal circulation, it is possible that placental cells are an
important source of HSC that eventually colonise the fetal liver.
Hemangioblastic cords appear to develop from mesodermal cells in the
chorionic villi.  However, it is possible that the growing placental HSC pool is
supplemented from sites associated with the developing vascular system
(e.g. AGM).  Both AGM and umbilical artery are immediately upstream of the
placenta in fetal circulation.  During the third trimester of pregnancy placenta
appears to lose its hematopoietic function while bone marrow develops into
the main site of hematopoiesis. Notwithstanding, the constantly changing
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placental vasculature most likely requires a constant supply of progenitor
cells.
1.3.4 Umbilical cord blood (UCB)
The umbilical cord contains blood vessels that carry oxygen and
nutrients from placenta to the embryo and wastes from the embryo to
placenta and the maternal circulation (Figure 2).  As umbilical cord is a
conduit linking the stem cell-rich placenta and the developing embryo, it
contains a large amount of HSPC throughout development.  For this reason,
stem cells isolated from UCB have been utilised successfully during
transplantation for almost twenty years (Kurtzberg et al., 2005).
UCB is typically collected ex utero following birth of the baby and
expulsion of the placenta.  This means that UCB can be considered an
ethical source of early stem cells as it can be collected without physical risk
to the mother or the baby donor.  UCB is an excellent source of HSPC and
the ethical collection of UCB has extended the availability of allogenic HSC
transplantation.  So far, HSPC isolated from UCB has been successfully
used in the treatment of patients with leukaemia, lymphoma,
hemoglobinopathies, bone marrow failure syndromes, congenital
immunodeficiency syndromes and inborn errors of metabolism (Kurtzberg et
al., 2005).  However, the use of UCB as a source of HSPC is not yet fully
optimised and many difficulties are associated with stem cells isolated from
UCB.
The use of UCB for transplantation in adults is limited by the small
number of HSPC in each graft, resulting in delayed engraftment post
transplant (Hofmeister et al., 2007).  Initial efforts to expand UCB
progenitors ex vivo have resulted in expansion of mature HSPC rather than
immature stem cells.  This is confounded by the inability to measure long-
term reconstituting cells aSccurately and reliably. The future of ex vivo
expansion should include isolation of immature hematopoietic progenitors on
the basis of function rather than surface phenotype and will employ physical
parameters, secreted factors and stroma to maintain and expand the stem
cell populations.  Improved understanding of HSPC developmental niches
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could promote HSPC ex vivo expansion with reduced differentiation and
make UCB transplantation available to more patients.
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2 OBJECTIVES
 The objectives of this study, which examined the impact of oxygen on
HSPC development and formation of a placental stem cell niche, included:
I. to establish an in vitro model of placental development and
vasculogenesis in physiological oxygen environments
II. to examine the influence of different physiological and non-
physiological oxygen concentrations on HSPC:
a) proliferation
b) cell cycle status
c) apoptosis
d) differentiation
III.       to characterise the SDF-1α - CXCR4 system during formation of
stem / progenitor cell niche in the placenta both in vivo and in
vitro.
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3 METHODS AND MATERIALS
3.1 Isolation of Primary Cells from Human Placentas
3.1.1 HSPC isolation
Human umbilical cord blood (UCB) was collected from term
pregnancies following ceasarian section as approved by the Ethics
Committee of the School of Medicine at Justus Liebig University, Giessen,
Germany.  Immediately following delivery, fetal blood was aspirated from
placental blood vessels into syringes containing heparin.  This method
resulted in an average of 53.2 ml of UCB (range 40-160 ml).  Following UCB
collection all steps were performed under sterile conditions in a laminar flow
hood.  UCB was diluted (1:4.5) in 2 µM ethylenediamine tetraacetic acid
(EDTA) in phosphate buffered saline (PBS) and 35 ml gently layered on 15
ml of 1.077 g/ml Ficoll-Paque Plus (Amersham Biosciences, Uppsala,
Sweden).  UCB was then subjected to density gradient centrifugation (400 x
g, 30 min, 20°C).  The mononuclear cell (MNC) fraction was removed and
pelleted by centrifugation (400 x g, 10 min, 20°C).  The resultant MNC pellet
was washed with 50 ml ice-cold MACS Buffer  (1X PBS, 5% Bovine Serum
Albumin (BSA), 2 µM EDTA), centrifuged (400 x g, 10 min, 4°C) and,
depending on pellet size, resuspended in 100-600 µl MACS Buffer.
To obtain pure populations of CD133 expressing MNC, Magnetic
Activated Cell Sorting (MACS) with the CD133 Cell Isolation Kit (Miltenyi
Biotech, Bergisch Gladbach, Germany) was employed.  Briefly, following
resuspension of the MNC pellet in ice cold MACS Buffer, cells were blocked
with 10 µl FcR Blocking Reagent/108 MNC (15 min, 4°C).  Cells were
subsequently labelled with 10 µl CD133 Microbeads/108 MNC and incubated
45 min on ice.  The cell suspension was then washed with 50 ml cold MACS
buffer and centrifuged (400 x g, 10 min, 4°C).  The supernatant was
removed, cells resuspended in 1 ml MACS Buffer (4°C) and the cell
suspension added to pre-rinsed MACS column placed in the magnetic field
of a VarioMACS Separator (Miltenyi).  Once the cell suspension was allowed
to pass through the MACS column, the column was washed 5 times with 4
ml ice cold MACS buffer and the flow-through collected in sterile 50 ml
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Falcon tube.  The column was removed from the magnetic field and bound
cells were eluted and flushed from the column with the supplied plunger into
a sterile 5 ml Falcon tube with 5 ml MACS Buffer (4°C).  Both collected cell
suspensions (i.e. CD133- and CD133+) were subsequently centrifuged (400
x g, 10 min, 4°C).  An aliquot of the cell suspension was removed, dead cells
were excluded using trypan blue staining and living cells were enumerated
with a hemocytometer.  This method resulted in an average retrieval of
1.0x106 CD133+ cells, for future reference labelled hematopoeitic stem /
progenitor cells (HSPC).
3.1.2 Trophoblast- and stroma-enriched cell fractions
isolation
MACS was similarly used to isolate cells from early human placental
tissue collected from elective abortions with written consent as approved by
the Ethics Committee of the Justus Liebig University School of Medicine.
The method used followed previously described protocols (Kliman et al.,
1986) with some modifications.  Tissue was thoroughly washed in Hank’s
Balanced Salt Solution (HBSS) to remove blood and chorionic villi were
removed from placental tissue and minced with a scalpel.  Enzymatic
digestion of minced chorionic villi fragments involved 3 times 20 min
incubations with trypsin-EDTA.  Following enzymatic digestion, collected
cells were subjected to magnetic cell sorting using CD326 (epithelial cell
adhesion molecule, EpCAM)-coated magnetic beads (Miltenyi Biotech).
CD326+ cells were subsequently labelled trophoblast-enriched cell fractions
(HTR).  Depleted CD326- cells resulted in a trophoblast-depleted or stroma-
enriched fraction.  Negatively selected cells are here called human placental
fibroblasts (HPF).
3.2 Cell Culture
3.2.1 HSPC expansion
Directly following isolation, HSPC were transferred to 15 ml tissue
culture flasks (TRP, Biochrom AG, Berlin, Germany) containing HSPC Growth
Media (HSPC-GM).  HSPC-GM consisted of Iscove’s Minimum Defined Media
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(IMDM) supplemented with 10% fetal calf serum (FCS), 10 ng/ml stem cell
factor (SCF), 20 ng/ml thrombopoietin (TPO) and 50 ng/ml Flt3-Ligand
(FLT3L) (all growth factors from PromoCell, Heidelberg, Germany).  Culture of
hematopoietic stem cells in this media has been shown to result in stem cell
proliferation and to maintain cells for extended culture periods (McGuckin et
al., 2003; McGuckin et al., 2004; McGuckin et al., 2005).  HSPC cell cultures
were expanded for 7 days in humidified incubators (37°C) in atmospheres
maintained with 5% CO2.  HSPC culture media was replaced every 3-4 days.
3.2.2 Adherent cell culture
Trophoblast-enriched (HTR) and placental stroma-enriched (HPF) cell
fractions were maintained in culture and used in a variety of experiments.
Directly following isolation, HTR in AmnioMax Serum-Free Media (including
penicillin/streptomycin) were allowed to attach to 15 mm2 plastic tissue
culture flasks for approximately 1 week in a humidified incubator (37°C, 5%
CO2).  On the other hand, HPF were cultured in Dulbecco’s Minimum
Essential Media (DMEM) containing 10% FCS.  HPF cultures were similarly
allowed to attach in 75 mm2 plastic tissue culture flasks for approximately 1
week.  Cell cultures were washed with warm media and unattached cells
were discarded.  HTR and HPF were first passaged when cell cultures
reached approximately 80% confluency.  Passaging was accomplished
using 5 min trypsinisation (Trypsin/EDTA, Gibco) followed by inactivation of
the enzyme with DMEM (10% FCS) and centrifugation (400 x g, 5 min).  Cell
pellets were resuspended in the appropriate media and further incubated.
This was considered passage 1 (P1).  Both HTR and HPF could be cultured
for a maximum of 6-7 passages (P6-7) before senescence.  P2-5 cells were
used during experimentation.
Conditioned media from HTR and HPF cultures was used in a variety
of experiments to test the effects of secreted factors on HSPC.  HTR or HPF
cells were expanded into 100 mm2 tissue culture flasks containing the
appropriate media (HTR: AmnioMax; HPF: DMEM (10% FCS)) and allowed
to reach ∼80 confluency.  The flasks were washed with 10 ml pre-warmed
PBS (3X) and media replaced with 12 ml serum-free IMDM (SFM).
Conditioned media was derived during 24 h cell culture.  Following cell
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culture, media was removed and subjected to high-speed centrifugation
(1000 x g, 30 min, 4°C) to pellet cells and cell debris.  Media was aspirated,
aliquoted and stored -80°C until needed.
3.2.3 Cell culture in low oxygen environments
Cell culture in environments containing low oxygen was used to
mimic physiologically relevant oxygen concentrations.  This was
accomplished by transferring cell cultures to a hermetically sealed,
humidified Modular Incubator Chamber (Billups-Rothenburg, Del Mar,
California USA) (Figure 6A).  Modular Incubator Chambers have previously
been used in multiple investigations in order to cultivate cells in low oxygen
as the air-tight seal and fast gas exchange allows for the rapid creation of a
low pO2 environment (Graven et al., 1994; Lee et al., 1997).
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Figure 6. Apparatus for cell culture in physiologically relevant
oxygen concentrations with concurrent real-time oxygen
monitoring. Cells were cultured in Oxyplate® 24 well plates in a
hermetically sealed, humidified cell culture chamber (A).  Plates
were placed on the Sensor Dish Reader (SDR) and the chambers
incubated at 37°C. Connection of SDR to computer (B) allowed for
real-time measurements of oxygen levels present in the cell culture
media during experimentation.
In this investigation, Modular Incubator Chambers were used to
simulate physiological oxygen tensions during cell culture.  Prior to the
experiments, all cell culture materials, including plastic cell culture plates
and dishes, media and oxygen monitoring equipment were preincubated for
2 h in appropriate oxygen concentrations.  The chamber was humidified
during the course of the experiment by placing a lidless, plastic petri dish
containing 20 ml sterile water on the bottom of the chamber.  Following
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preincubation, cell cultures were transferred to the Modular Incubator
Chamber and the chamber sealed.  A Single Flow Meter (Billups-
Rothenburg) was attached to inflow tube, connected to the gas flask and
was used to control the flow of the gas into the chamber.  The outflow tube
was opened and the chamber flushed with appropriate gas mixtures for 4
min at a rate of 20-25 l/min.  The gas mixtures used in this reports consisted
of either 1% or 8% O2 (5% CO2 and rest N2).  Inflow and outflow tubes were
sealed following gassing, creating a hermetically sealed chamber.  The
sealed Modular Incubator Chamber was then placed in a 37°C incubator and
the atmosphere was replaced with the appropriate gas mixture 3 times daily
for the duration of the experiments.  As a control, HSPC were cultivated in
normal cell culture conditions by incubating cells in atmospheric oxygen
(21% O2, 5% CO2, rest N2) in a humidified cell culture incubator (37°C).
3.2.4 Concurrent real-time oxygen measurements
During experimentation a prototype oxygen monitoring system was
employed in order to concurrently monitor real-time oxygen tension of HSPC
culture media.  The 24-channel Sensor Dish Reader 2 (SDR2; PreSens,
Regensburg, Germany) has been developed to control important
parameters, such as pH and oxygen tension, during cell culture.  This was
accomplished by the integration of opto-chemical sensors in each well of a
sterile 24-well multidish (OxyPlates® monitor oxygen; HydroPlates® monitor
pH).  Sensors consisted of fluorescent dyes embedded in a cell culture
compatible polymer placed at the bottom of each well.  Cells in cell culture
media were then seeded into the wells and the plates placed on the SDR
plate reading device.  The SDR system was connected to a PC allowing
system control and data collection (Figure 6B).  Optical signals were
collected by the SDR at specific time points (ranging from every 10 sec to
every 30 min) and the data transmitted to PC.
The prototype SDR2 system was tested in this investigation and used
to measure oxygen tensions in our HSPC cultures.  To allow for
measurements in low oxygen environments the Modular Incubator Chamber
was modified to allow insertion of the SDR2 plate reader into the
hermetically sealed chamber.  Selection of appropriate gas mixtures allowed
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in vivo oxygen tensions to be effectively mimicked during in vitro HSPC
culture.  Similarly, this novel system allowed oxygen tensions in HSPC
culture media to be monitored during experimentation.
3.3 HSPC Proliferation Assay
Cell number was determined with a CASY® Cell Counter (Shaerfe
Systems, Reutlingen, Germany).  The CASY® Cell Counter is an established
method for determining cell number utilising the Resistance Measurement
Principle.  Briefly, 50 µl of cell suspension was removed from each of the
groups and mixed with 10 ml CASY®ton electrolyte solution (Schaerfe
Systems) and placed in the CASY® Cell Counter.  Measurement was
performed when the cell suspension was aspirated with a 150 µm capillary
and single cells passed through a pore of defined geometry at a constant flow
speed.  A pulsed low voltage electrical current was applied over the
electrolyte-filled measuring pore, representing a defined electrical resistance.
As cells passed through the measurement pore a quantity of the electrolyte
was displaced.  Living intact cells acted as insulators with the resistance
representing a dimension for cell volume.  Dead cells without an intact cell
membrane could no longer act as an electrical barrier and were therefore
recorded by the size of the cell nucleus.  Thus, living HSPC could be
discriminated from dead HSPC and debris based on relative size.
HSPC cultures were expanded for 7 days in HSPC-GM as described
above.   Attached cells were scraped with a plastic cell scraper (Cellstar,
Greiner Bio-One, Frickenhausen, Germany) and both the previously attached
and suspended cells were collected.  The cell suspension was subsequently
centrifuged (400 x g, 10 min), the supernatant removed and the cell pellet
resuspended.  Initial cell number was determined with trypan blue exclusion.
2x105 HSPC were added to each well of a 24-well plate and the plates
incubated in the specified conditions (HSPC-GM, HTR-CM, HPF-CM) in
various oxygen concentrations (1%, 8% and 21% O2).  Media was replaced
and cell number was determined with a CASY® Cell Counter on days 8, 10, 12
and 14.
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3.4 Flow Cytometry
In this investigation flow cytometry was employed to quantify cellular DNA
content, and apoptosis, as well as for immunophenotyping.
3.4.1 Flow cytometric cell cycle analysis
HSPC cell cycle status and DNA content were quantified using
propidium iodide (PI) staining of fixed cells followed by flow cytometric
analysis.  This method was based on stochiometric intercalation of PI
between the bases of double-stranded nucleic acids.   Individual cell ploidy
could be assessed with a flow cytometer.  Resting cells in G0 and cells
preparing for DNA synthesis in G1 have a 2n ploidy; cells preparing for cell
division in G2 and cells undergoing mitosis (M) have 4n.  As PI binding to
DNA was stochiometric, the measured fluorescence intensities of PI treated
cells was related to the number of DNA molecules.  Thus, G0/G1 cells have
fluorescence intensities representing one-half of G2/M cells.  Cells found
between these two peaks represent cells synthesising DNA (S phase) with
ploidy between 2n and 4n. The protocol utilised in this investigation was as
follows.
HSPC cultures were expanded for 7 days as previously described.
HSPC were plated 1.5x105 cells/ml on 12-well plates (Cellstar, Greiner Bio-
One, Frickenhausen, Germany) and incubated in environments containing
1%, 8% or 21% O2.  On Days 7, 8, 10 and 14, 1x105 HSPC were removed,
centrifuged (400 x g, 10 min, 4°C) and washed two times in ice-cold PBS.
HSPC membranes were permeabilised by overnight fixation in 70% ethanol
(-20°C).  Fixed cells were centrifuged (400 x g, 10 min), the ethanol removed
and the cell pellet resuspended in 100 µl 1% BSA in PBS.  To avoid
propidium iodide (PI) incorporation into double-stranded ribonucleic acid
(RNA), cellular RNA was digested with 100 µg/ml DNase-free RNase
(Roche Applied Sciences, Mannheim, Germany) for 20 min at 37°C.  Cells
were subsequently incubated with 10 µg/ml PI (Becton Dickinson (BD),
Heidelberg, Germany) for 1 h in the dark.  In preparation for flow cytometry,
total volume was adjusted to 500 µl and suspensions vortexed to mix the
cells.
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PI incorporation into HSPC DNA was measured with the FACSCalibur
(BD) flow cytometer with CellQuest Pro hardware (BD). Whole cells were
first gated based on their Forward Scatter (FSC) and Sideward Scatter
(SSC) properties, with particles exhibiting both low FSC and SSC excluded.
PI fluorescence intensity was demonstrated by plotting FL2-Area versus
FL2-Width.  Data was subsequently analysed with ModFit Analysis Software
(BD).
3.4.2 Flow cytometric apoptosis assay
The level of HSPC apoptosis following various treatments was
measured using the Annexin V-FITC Apoptosis Detection Kit (Becton
Dickinson).  This particular assay utilises Annexin V as a sensitive probe for
identifying apoptotic cells.  During early apoptosis, loss of the plasma
membrane is one of the earliest features.  In early apoptotic cells the
membrane phospholipid phosphotidylserine (PS) is translocated from the
inner to the outer leaflet of the plasma membrane, thereby exposing PS to
the cellular environment.  Annexin V is a phospholipid-binding protein with
high affinity for PS.  Annexin V conjugation to a fluorochrome such as FITC,
therefore, creates a sensitive probe for flow cytometric analysis of cells
undergoing apoptosis (Vermes et al., 1995).  In the Annexin V-FITC
Apoptosis Detection Kit I, PI was utilised as a marker for cells that have lost
plasma membrane integrity, such as late apoptotic or dead cells, which
further strengthened the assay.  A requirement for PI intercalation into
cellular nucleic acids is a permeabilised cell membrane that allows passage
of PI into the cell.  Therefore, PI staining could only be seen in cells that
were losing (i.e. late apoptotic cells) or had already lost (i.e. dead cells) cell
membrane integrity.  Following flow cytometric analysis of the cultures, cells
could be categorised.  Viable cells were negative for both Annexin V and PI
while cells undergoing early apoptosis were positive for Annexin V and
negative for PI.  Finally, cells that were in late apoptosis or have died as a
result of the necrotic pathway were positive for both Annexin V and PI
(Figure 7).
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Figure 7. Explanation of data obtained from HSPC apoptosis
assay.  Results from flow cytometric analysis are displayed as a
dot plot diagram. The plot is divided into four quadrants. The bottom
left quadrant represents live cells with an intact cell membrane. The
bottom left quadrant represents early apoptotic cells where Annexin
V-FITC (seen in green) binds to phosphatidylserine in the outer cell
membrane. The upper right quadrant represents late apoptotic or
dead cells where Annexin V-FITC binds the outer membrane and PI
can pass freely into the nucleus.
In this investigation, HSPC were subjected to the Annexin V-FITC
Apoptosis Detection Kit (BD).  Apoptosis levels were then tracked over a
further incubation period in different oxygen concentrations.  The supplied
protocol was used.  Following expansion of HSPC cultures, cell number was
quantified with trypan blue exclusion.  4.5x105 HSPC/treatment were
removed, divided into three groups (1.5x105 HSPC/group) and plated in one
well of a 12-well cell culture plate (Cellstar, Grener Bio-One, Frickenhausen,
Germany).  The three groups represented: i. unstained controls for setting
the flow cytometer parameters, ii. stained HSPC for the apoptosis assay and
iii. staurosporine treated HSPC (Alexis Biochemicals, Gruenberg, Germany).
In the third group, HSPC were pre-treated with the apoptosis-inducing
antiobiotic (Bertrand et al., 1994) staurosporine (30 nM, 24 h).  Plates were
then incubated at 37°C in a humidified environment containing 1%, 8% or
21% O2 as previously described.  At each time point, cells were removed
from their wells by scraping with a plastic cell scraper (TRP).  HSPC were
transferred to 12 ml tubes and retrieved from the media by centrifugation.
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2x105 HSPC were washed twice with 5 ml ice cold PBS, resuspended in 1X
Annexin V Binding Buffer (0.1 M Hepes/NaOH (pH 7.4), 1.4 M NaCl, 25 mM
CaCl2) and transferred to flow cytometry tubes (BD).  Excluding the
unstained controls, all HSPC were then incubated with 5 µl of both Annexin
V-FITC and PI (15 min, RT).  Following incubation the final volume was
adjusted to 500 µl with 1X Annexin V Binding Buffer.  Annexin V-FITC and
PI staining of HSPC was subsequently analysed with FACSCalibur (BD).
3.4.3 Immunophenotypic characterisation
Following expansion, HSPC cultures were cultured in 6-well plates
placed in 1%, 8% and 21% O2 as described previously.  HSPC were
subjected to flow cytometric immunophenotyping at days 7, 10 and 14.
Cells were removed from 6-well plates by scraping with a plastic cell scraper
followed by aspiration of culture media.  HSPC were pelleted by
centrifugation (400 x g, 10 min, 4°C) and pellets washed twice with ice cold
PBS.  Following washing, cells were resuspended in 100 µl PBS.  Incubating
HSPC with human serum for 15 min on ice blocked non-specific binding.
Cells were subsequently labelled with specific antibodies (Chart 1).  Labelled
cells were then quantified with the FACSCalibur flow cytometer and the data
analysed with CellQuest Software (BD).
Chart 1. Antibodies for flow cytometry.
Concentration
Antibody Fluoro-
chrome
Host
Species
Ig
Subtype Stock End
Company
Fluorochrome-Conjugated Primary Antibodies:
CD11b PE Mouse IgG2a 50 µg/ml 2.50 µg/ml BD Biosciences
CD13 APC Mouse IgG1 20µl/106 cells 5 µl BD Biosciences
CD14 PerCP Mouse IgG2b 25 µg/ml 1.25 µg/ml BD Biosciences
CD18 FITC Mouse IgG1 25 µg/ml 1.25 µg/ml BD Biosciences
CD31 FITC Mouse IgG1 20µl/106 cells 5.00 µl BD Biosciences
CD33 R-PE Mouse IgG1 20µl/106 cells 3.00 µl BD Biosciences
CD34 FITC Mouse IgG2a 55 µg/ml 2.75 µg/ml Miltenyi Biotech
CD45 PerCP Mouse IgG1 25 µg/ml 1.25 µg/ml BD Biosciences
CD117 APC Mouse IgG1 20µl/106 cells 0.80 µl BD Biosciences
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Antibody Fluoro-
chrome
Host
Species
Ig
Subtype Concentration Company
CD133 PE Mouse IgG1 55 µg/ml 2.75 µg/ml Miltenyi Biotech
CD140b R-PE Mouse IgG2a 20µl/106 cells 5 µl BD Biosciences
Tie-2 PE Mouse IgG1 50 µg/ml 4 µg/ml R&D Systems
CXCR4 Cy5-PE Mouse IgG1 20µl/106 cells 5 µl BD Biosciences
Unconjugated Primary Antibodies:
CD29/
β1 integrin -- Mouse IgG1 25 µg/ml 1 µg/ml Serotec
CD49d/
VLA-4/
α4 integrin
-- Mouse IgG1 25 µg/ml 5 µg/ml Serotec
VEGFR-1 -- Mouse IgG1 1000 µg/ml 10 µg/ml Abcam
VEGFR- 2 -- Goat IgG 1000 µg/ml 10 µg/ml R&D Systems
Fluorochrome-Conjugated Isotype Control Antibodies:
FITC Mouse IgG1 20µl/106 cells 5 µl BD Biosciences
APC Mouse IgG1 20µl/106 cells 5 µl BD Biosciences
PE Mouse IgG1 50 µg/ml 4 µg/ml R&D Systems
R-PE Mouse IgG1 20µl/106 cells 3 µl BD Biosciences
FITC Mouse IgG2a 20µl/106 cells 5 µl BD Biosciences
PE Mouse IgG2a 20µl/106 cells 5 µl BD Biosciences
PerCP Mouse IgG1 20µl/106 cells 5 µl BD Biosciences
Cy5-Pe Mouse IgG1 20µl/106 cells 5 µl BD Biosciences
Unconjugated Isotype Control Antibodies
- Mouse IgG1 1000 µg/ml 10 µg/ml Abcam
- Mouse IgG1 20µl/106 cells 5 µl BD Pharmingen
- Mouse IgG1 20µl/106 cells 5 µl Serotec
Fluorochrome-Conjugated Secondary Antibodies
APC
Goat
(anti-
mouse)
IgG 20µl/106 cells 1 µl BD Biosciences
PE
Rabbit
(anti-
goat)
IgG 500µg/ml 0.5 ug/ml Dianova
3.5 Gene Expression Analysis
In this investigation, two-step reverse transcriptase-polymerase chain
reaction (RT-PCR) was employed to examine changes in gene expression
following incubation of HSPC in different oxygen concentrations.
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3.5.1 RNA isolation
HSPC were transferred to 6-well plates (CellStar) and incubated in
21%, 8% or 1% O2 for 7 days.  On days 7, 10, 12, and 14 adherent HSPC
were first scraped with a plastic cell scraper and the cells aspirated.  HSPC
were pelleted by centrifugation (400 x g, 10 min, 4°C) and washed two times
in ice cold PBS.  Cells were lysed with the QIAshredder Kit (QIAGEN,
Hilden, Germany) followed by RNA isolation utilising the RNeasy Mini Kit
(QIAGEN).  RNA isolated using this technique was then quantified with a
spectrophotometer (BioRad, SmartSpec 3000), aliquoted and stored at -
80°C until required.
3.5.2 First-strand synthesis
First strand cDNA synthesis was performed with SuperScript™ II
Reverse Transcriptase Kit (Invitrogen Corporation, Karlsruhe, Germany).
Reactions were mixed according to provided recipes.  1 µg of RNA isolated
from the previous step was mixed with 0.5 µg random primers (Promega,
Madison, Wisconsin USA) and deionized H2O to a total volume of 12 µl.
Primers consisted of random hexadeoxynucleotides and allowed for
amplification of first strand cDNA from the total cellular messenger RNA
(mRNA) pool.  The mixture of RNA, random primers and H2O was
subsequently heated to 70°C for 10 min in a PCR cycler (Eppendorf
Mastercycler Gradient) followed by cooling 2 min on ice.  To this mixture, 4
µl of 5X First-Strand Buffer (250 mM Tris-HCL (pH 8.3), 375 mM KCl, 15 mM
MgCl2), 2 µl 0.1 M DTT and 1 µl of 10 mM dNTP Mix was added.  The
resultant mixture was then heated for 2 min at 42°C.  Finally 1 µl (200 units)
of SuperScript™ RT was added and mixed by pipetting.  The final 20 µl
mixture was then incubated for 50 min at 42°C and the reaction inactivated
by heating to 70°C for 15 min.  cDNAs were stored at 4°C until required.
3.5.3 Gene-specific PCR amplification
Gene-specific primers (Chart 2) were used in combination with
AccuPrime™ Taq DNA Polymerase (Invitrogen Corporation) to examine
changes in HSPC gene expression following incubation in low oxygen.  This
particular kit includes anti-Taq DNA polymerase antibodies that inhibit
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polymerase activity, providing a “hot-start” thereby permitting room
temperature setup.  50 µl reactions were mixed according to supplied
protocol.  In 0.2 ml thin-walled PCR Tubes (Biozym Scientific GmBH,
Oldendorf, Germany), 200 ng template previously synthesised cDNA was
mixed with 10 µM primer, 5 µl of 10X AccuPrime™ PCR Buffer I or II
(depending on product length), 1 µl AccuPrime™ Taq DNA Polymerase and
distilled, deionized H2O to a 50 µl total volume.  PCR amplifications were
carried out in the PCR Cycler according to the general program (initial
denaturation at 45°C for 2 min, denaturation at 45°C for 30 sec, annealing
(see Chart 2 for specific annealing temperatures), elongation at 72°C for 1
min per kbase, 35 cycles, and final elongation at 72°C for 5 min).
Chart 2. Primers employed during RT-PCR.
Name Primer Sequence(5’→3’)
Product
Size TAnneal Reference
CD117 F: ATTTTCTCTGCGTTCTGCTCCTACR: CGCCCACGCGGACTATTA 128bp 56°C (Uccini et al., 2005)
CD133 F: TACCAAGGACAAGGCGTTCACR: CAGTCGTGGTTTGGCGTTGTA 469bp 55°C (Baal et al., 2004)
FGF4 F: CTACAACGCCTACGAGTCCTACAR: GTTGCACCAGAAAAGTCAGAGTTG 370bp 55°C (Henderson et al., 2002)
Flt1 F: GCACCTTGGTTGTGGCTGACTR: CCCTTCTGGTTGGTGGCTTTG 655bp 60°C (Krussel et al., 1999)
GATA1 F: TCAATTCAGCAGCCTATTCCR: TTCGAGTCTGAATACCATCC 377bp 50°C* (Chadwick et al., 2003)
GATA2 F: TGTTGTGCAAATTGTCAGACGR: CATAGGTGCCATGTGTCCAGC 275bp 53°C (Hirasawa et al., 2002)
HIF1α F: ACAAGTCACCACAGGACAR: AGGGAGAAAATCAAGTCG 168bp 50°C (Bilton et al., 2005)
KDR F: AGACTTTGAGCATGGAAGR: CCATTCCACCAAAAGATG 298bp 49°C (Henderson et al., 2002)
Oct4 F: GGGCTCGAGAAGGATGTGGTR: GGGCTCCCATAGCCTGGG 182bp 55°C
sequence supplied by
Chemicon (Temulca, USA)
Rex1 F: CAGCATCCTAAACAGCTCGCAGAATR: GCGTACGCAAATTAAAGTCCAGA 306bp 55°C (Henderson et al., 2002)
RUNX1 F: CCGCAGCATGGTGGAGGTAR: AGCGATGGGCAGGGTCTTG 121bp 56°C (Taniuchi et al., 2002)
SDF-1 F: GTGTCACTGGCGACACGTAGR: TCCCATCCCACAGAGAGAAG 263bp 55°C (Ceradini et al., 2004)
Sox1 F: CTCACTTTCCTCCGCGTTGCTTCCR: TGCCCTGGTCTTTGTCCTTCATCC 838bp 63°C (Henderson et al., 2002)
Sox2 F: CCCCCGGCGGCAATAGCAR: TCGGCGCCGGGGAGATACAT 448bp 60°C (Henderson et al., 2002)
VEGF165 F: AGGCCAGCACATAGGAGAGAR: AACAAATGCTTTCTCCGCTC 123bp 54°C (Hollingsworth et al., 2005)
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3.6 Immunofluorescence Microscopy
3.6.1 Immunohistochemistry
Placental probes (gestational ages including 6, 12, and 38 wpc) were
collected and either directly embedded in Tissue-Tek OTC (Sakura,
Torrance, CA) and immersed in liquid nitrogen, or pre-fixed for 1 h in
Zamboni´s solution, washed and embedded in OTC before cryoslicing (8
µm).
Tissue slices were blocked with 10% donkey serum (Jackson
ImmunoResearch, West Grove, PA) and then incubated overnight at 4°C
either with monoclonal mouse anti-human CD34 (1:100; DakoCytomation,
Hamburg, Germany), or with monoclonal mouse anti-human SDF-1 (1:100;
R&D Systems) diluted in PBS supplemented with 1% donkey serum and
0.1% Triton X-100.  As secondary antibody, affinity-purified RhodRedX-
donkey anti-mouse IgG (Jackson ImmunoResearch), diluted 1:400, was
then applied for 1 h at room temperature.  After three washing steps, excess
mouse IgG-binding activity was blocked by 30 min incubation with 10%
mouse serum (Jackson ImmunoResearch) at room temperature.  The slices
were then incubated for 60 min with FITC-labeled monoclonal mouse anti-
human cytokeratin 7 (DakoCytomation), washed, and nuclei were
counterstained with Hoechst 33342 (5 µg/ml; Calbiochem, Darmstadt,
Germany) before mounting in ProLong Gold antifade reagent (Molecular
Probes, Invitrogen, Karlsruhe, Germany).  Further slices were first incubated
overnight at 4°C with a mixture of polyclonal goat-anti-human vimentin (S-
20; 1:200, Santa Cruz Biotechnology, Santa Cruz, CA) and anti-human
SDF-1 (1:100), and then for 1 h at room temperature with a mixture of
affinity purified FITC-donkey anti-goat IgG and RhodRedX-donkey anti-
mouse IgG.  Controls for nonspecific staining were performed by replacing
primary antibodies with mouse isotype controls.  Fluorescence was
observed with a Leica DM-LB microscope (Wetzlar, Germany) equipped with
a Leica DC-200 camera, Leica IM 1000 software and filters for blue light
(505 nm), green light (580 nm), and UV-light (400 nm) excitation.
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3.6.2 Immunocytochemistry
Immunocytochemistry was performed on placental stroma-enriched cell
fractions (HPF) cultured in either 1% or 8% O2 to examine in vitro
expression of SDF-1α protein.  HPF were added to 8-well chamber slides
(LabTek, Nunc, Wiesbaden, Germany) and allowed to attach overnight in
ambient atmospheres.  The following day, HPF were transferred to
atmospheres containing the appropriate oxygen concentrations and
incubated a further 2 days, as described above.  Following incubation,
cultures were washed with PBS and fixed for 15 min in Zamboni’s solution.
Fixed HPF were subsequently washed in PBS (3 X 5 min), blocked for 1 h in
10% donkey serum (PBS; 1% BSA, 0.1% Triton X-100) and incubated for 2
h with a 1:100 dilution of mouse monoclonal anti-human SDF-1α antibody
(R&D Systems) or the appropriate isotype-matched control.  Slides were
washed 3 times in PBS, incubated for 1 h in a 1:100 dilution of Rhodamine
Red-conjugated donkey anti-mouse IgG and washed again in PBS (3 X 5
min).  Nuclei were stained for 5 min with Hoechst 33342 (5 µg/ml).  Cover
slides were mounted with ProLong Gold antifade reagent, fluorescent cells
visualised with a Nikon fluorescence microscope (Nikon TE2000,
Duesseldorf, Germany) and images captured using NIS Elements AR v2.3
software (Nikon).
3.7 Human SDF-1α Immunoassay
SDF-1α protein secretion into media conditioned during culture of
mixed placental cells, Jeg3 choriocarcinoma cells, HTR and HPF cells was
determined using Quantikine® Human SDF-1α Immunoassay (R&D Systems,
Wiesbaden, Germany).  This assay employs the quantitative sandwich
enzyme immunoassay technique, in which, a specific SDF-1α monoclonal
antibody has been pre-coated onto a microplate.  Immobilised antibody binds
SDF-1α present in samples and standards while unbound substances are
washed and removed from the microplate.  A second incubation with an
enzyme-linked polyclonal antibody specific for SDF-1α facilitates colourimetric
detection of bound SDF-1α; following addition of substrate, colour develops in
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proportion to the amount of SDF-1α present.  SDF-1α ELISA was performed
according to the manufacturer’s description.  Briefly, 200 µl of standard or
sample was incubated in the provided 96-well plate for 2 h at room
temperature.  Wells were washed 3 times and further incubated with SDF-1
conjugate for an additional 2 h with shaking at room temperature.  Following
this incubation, wells were washed 3 times with wash buffer.   200 µl of
substrate solution was added and plates incubated for 30 min (RT).
Colourimetric detection determined SDF-1α levels by first measuring
absorbance at 450 nm and relating sample absorbance to specific standards.
All samples and standards were examined in triplicate.  Immunoassays were
repeated a minimum of 3 times.  In concordance with the manufacturer’s
description, intra- and interassay variability were within acceptable ranges.
3.8 In Vitro Migration Assays
Migratory capacity or the ability of HSPC to migrate through a
membrane with 3 µm pores under various treatment conditions was measured
using a modified Boyden Chamber assay.  Each well of 24-well plate
consisted of an upper insert separating the well with a membrane.  2.5x105
cells/200 µl IMDM (± 1 µg/ml AMD3100) was added in the inserts and placed
into the lower well containing 800 µl of IMDM, conditioned media (HTR-CM,
HPF-CM), or SDF-1α-supplemented IMDM (1% FCS; 0.025% BSA).  Plates
were incubated in a humidified atmosphere for the specified times at 37ºC.
Inserts were removed and migrated HSPC were quantified with a Casy® Cell
Counter (Schaerfe Biosystems).
3.8.1 Transendothelial migration
Transendothelial migration (TEM) of HSPC was assayed utilising a
similar technique.  Prior to the addition of HSPC, inserts were coated with a
monolayer of human umbilical vein endothelial cells (HUVEC, P3-4) isolated
according to established protocols.  HSPC were fluorescently stained
(PKH26 Red Fluorescent cell stain; Sigma, Munich Germany) before being
included.  TEM assays were carried out for the specified time under the
same conditions as described above.  In some cases, the effects of
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placental cell types on HSPC TEM were assayed by coculturing specific
placental cell types as monolayers coating the bottom well.  Where
specified, cocultured cells were pretreated for 24 h in different oxygen
concentrations (1% or 8% O2).  Migrated HSPC were quantified by
measuring the number of PKH+ event counts in 90 sec with FACSCalibur
(BD).
3.9 In Vitro Cell-Cell Adhesion Assay
Following expansion, the ability of HSPC to adhere to placental-derived
cells was assessed.  Briefly, HSPC were fluorescently stained (PKH26) and
2.5x105 HSPC were incubated in 24-well plates containing a human placental
cell monolayer.  After 6 h incubation in different oxygen concentrations (1%,
8% or 21% O2), non-adherent HSPC were collected, the wells washed 3 times
with cold PBS; all washes were collected.  Adherent cells were lifted with
trypsin-EDTA and collected.  The number of PKH+ HSPC in both the non-
adherent and adherent fractions was determined using FACSCalibur.  Cells
were quantified by measuring the number of HSPC events in 90 sec and the
ratio of adherent HSPC to the total number of HSPC calculated.
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4 RESULTS
4.1 Detection of CD34 Positive Cells in Early Human Placental Tissue
Human placental tissue was examined for expression of CD34 during
various stages of development (Figure 8).  Tissues were probed with specific
fluorochrome-coupled antibodies recognising human CD34 and human
cytokeratin 7.  CD34 is a common marker for both hematopoietic and
endothelial progenitor cells.  Cytokeratin is commonly used to distinguish
endodermal cells from mesenchymal cells and in the human placenta,
cytokeratin 7 specifically labels cells of the trophoblast lineage.
B.  Early Placenta (12 wpc)
Cytokeratin 7 CD34 Merge
A.  Early Placenta (6 wpc)
Cytokeratin 7 CD34 Merge
Figure 8. Immunohistochemical analysis of CD34 expression in
early human placental tissue. Unfixed human tissue from 6 wpc
and 12 wpc were labelled with anti-human CD34 (Red) and anti-
human cytokeratin 7 (Green) antibodies. Photomicrographs were
made and images merged. CD34 expression was seen on
individual cells and cord-like structures in placental villi at 6 wpc
(A). In 12 week-old placental tissue (B), CD34 labelled individual
cells and early blood vessels within the chorionic villi. Cell nuclei
were stained with Hoechst (Blue). Original magnification 200X.
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Early human placental tissue contains CD34+ cells and CD34+ cell clusters
at 6 wpc as demonstrated by immunohistochemistry (Figure 8).  CD34+ cells
did not stain positive for cytokeratin 7.  A similar staining pattern was seen in
12 week-old human placental tissue (Figure 8B).  At this time point, a greater
number of CD34+ cells were situated within the placental stroma, indicating an
increase in the number of placental blood vessels.  Some CD34+ cells could
be in found in proximity to trophoblast.
4.2 Flow Cytometric Analysis of HSPC
HSPC isolated from human UCB from term pregnancies were
characterised utilising flow cytometry analysis based on the expression of CD
(cluster of differentiation) cellular antigens (Chart 3).
Chart 3. Phenotypic characterization of HSPC (Day 0 and Day 7).
Positive Cells ( % )
CD133 / CD34 CD133 / CD117 CD45 CD11b / CD14
Day  0 87.5 84.6 98.6 1.0
Day  7 13.6 15.4 98.3 3.9
In this investigation, HSPC were isolated utilising anti-CD133 antibody
coated microbeads.  Directly following isolation (Day 0), HSPC were 88%
double positive for CD133 and CD34 demonstrating the effectiveness of this
technique in the isolation of HSPC.  The majority of CD133+ cells were also
positive for the stem cell marker CD117 (c-kit / SCF receptor) at the time of
isolation.  HSPC were also CD45+.  Only 1% of freshly isolated HSPC
expressed the combination of CD11b and CD14, commonly used as markers
for differentiated monocytes.
 In our laboratory, seven-day culture expansion was required to provide
a sufficient number of HSPC for various functional studies.  Furthermore,
following seven-day culture expansion in HSPC growth media (HSPC-GM), an
appropriate number of HSPC remained in culture.  At Day 7, HSPC remained
13.6% CD133 and CD34 double positive (Chart 3).  The majority of CD133+
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cells also expressed CD117.  Almost all cells in the HSPC expressed CD45+
(98.3%).  A significant difference was noted in the expression of monocyte
markers between Day 0 and Day 7.  The number of cells coexpressing the
monocyte markers CD11b and CD14 rose from 1% on Day 0 to 4% on Day 7.
These results demonstrate the effective isolation of HSPC expressing
CD133, CD34 and CD117.  Seven-day expansion of HSPC cultures was also
shown to be an effective method for increasing cell number while maintaining
a pool of HSPC.  In accordance with previously published results, isolated
HSPC demonstrated progenitor capabilities (Baal et al, 2004)
4.3 Placental Oxygen Tensions Can Be Effectively Mimicked In Vitro
A novel system has been used in our laboratory to measure real-time
oxygen concentrations in HSPC media during culture (see Figure 6).
Following optimisation of the procedure, three distinct atmospheric
compositions were chosen, including mixtures containing either 1% or 8% O2
(with 5% CO2) or atmospheric oxygen (21% O2).  Particular low oxygen
concentrations were chosen in order to reproduce placental oxygen tensions
previously measured in vivo and reported (Rodesch et al., 1992; Jauniaux et
al., 1999; Jauniaux et al., 2001).  Replacement of the gas mixture in the
chambers resulted in a rapid reduction in O2 level followed by a period of
equilibration (Figure 9).  During standardisation of the protocol it was
demonstrated that atmosphere replacement three times daily (1 time/h for 3 h,
4 min gas flow at 25 mm/h) was required to maintain appropriate oxygen
tensions over time.
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Figure 9. HSPC media oxygen tensions during culture in 1%,
8% or 21% O2. The SDR system concurrently monitored oxygen
concentrations during a two-day experimental period.
Representative graph is shown demonstrating in vitro oxygen
tensions (pO2) during HSPC culture in low oxygen (1% O2: open
triangles; 8% O2: black squares). An average oxygen tension of
10.2 ± 5.5 mmHg was encountered when HSPC were cultured in
1% O2. In 8% O2, the average oxygen tension was 65 ± 7.5 mmHg.
When HSPC were cultured in ambient oxygen (21% O2: grey
circles) the average oxygen tension in HSPC culture media was
157.9 ± 9.2 mmHg. Atmospheres in low oxygen environments were
changed three times daily (black arrowheads).
When HSPC were cultured in an atmosphere containing 8% O2, a
mean pO2 of 65.0 ± 7.5 mmHg was maintained.  This environment is similar to
measurements made in placental beds from pregnancies at 10-15 wpc (65.0 ±
3.4 mmHg).  When HSPC were cultured 1% O2, the mean pO2 measured was
10.2 ± 5.5 mmHg.  These oxygen tensions were similar to previously
described physiological pO2 in the fetoplacental unit at 8-10 wpc (17.9 ± 6.9
mmHg).  This clearly demonstrates the effectiveness of the described, novel
system in mimicking actual physiological oxygen tensions at different time
points during placental development.  As comparison, HPSC cultured in
ambient oxygen were similarly assessed.  HSPC grown under atmospheric
conditions encountered non-physiological, high oxygen environments (Figure
9).  A mean in vitro pO2 of 157.9 ± 9.2 mmHg was reached, illustrating that
culture in ambient oxygen results in a clearly hyperoxic environment.
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4.4 Effect of Physiological Oxygen Levels on HSPC Number
Cell number was measured with a Casy® Counter during HSPC culture
in physiological oxygen concentrations (1% and 8% O2).  The effect of low
oxygen during HSPC expansion in HSPC-GM was assayed (Figure 10).
HSPC cell number in hyperoxic conditions (21% O2) was likewise quantified.
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Figure 10. HSPC number during culture in different oxygen
concentrations.  HSPC (Day 7) were cultured with HSPC-GM in
low oxygen environments containing 1% (open triangles) or 8% O2
(black squares). HSPC number was quantified on days 10, 12, and
14. HSPC expansion in ambient oxygen (21% O2) was also
examined (grey circles). HSPC number positively correlated with
oxygen concentration.
HSPC cultivation with HSPC-GM (IMDM, 10% FCS + 50 ng/ml Flt3L,
20 ng/ml SCF, and 10 ng/ml TPO) in ambient oxygen induced expansion of
HSPC and was used to amplify HSPC cultures directly following isolation.
Results demonstrated that additional culture of HSPC beyond Day 7 with
HSPC-GM in 21% O2, resulted in a >7-fold increase in HSPC number.  In fact,
previous work in our laboratory has shown that proliferation of cultures
continued for ~30 days, after which, HSPC number could be maintained up to
60 days (Baal et al., 2004).
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The number of HSPC positively correlated with oxygen concentration
(Figure 10).  HSPC in high oxygen environments (21% O2) continued
expanding during the 7 day experimental period.  HSPC number slightly
increased in 1% and 8% O2 but did not result in substantial expansion when
compared to culture in ambient oxygen.  Minimal HSPC expansion occurred in
atmospheres containing the lowest oxygen concentration (i.e. 1%).
Approximately 3-fold and 2-fold increases in cell number were seen after 7
day culture of HSPC in 8% and 1% O2, respectively.  Cell death, as assessed
with the Casy® Counter was not affected by culture of HSPC in low oxygen
concentrations.
These results demonstrate the effects of oxygen tensions on HSPC cell
number.  Traditional cell culture conditions have been shown to result in
HSPC expansion.  However, when HSPC were grown in oxygen tensions
more effectively mimicking those found in utero, decreased culture expansion
was seen.
4.5 HSPC Cell Cycle Analysis
As culture of HSPC in 1% and 8% O2 was shown to affect cell
proliferation, further experiments examined the effects of physiological oxygen
tensions on HSPC cell cycle status.  This was accomplished using propidium
iodide (PI) staining of fixed HSPC followed by quantification of cell ploidy with
flow cytometry and ModFit® software.
Cells (Figure 11A, Region 1 (R1)) were first gated based on their size
(FSC) and granularity (SSC).  Cell aggregates resulting from the fixation
process were excluded with further gating (Figure 11B, R2).  Using this
technique, 2n cells in G2 or M phase of the cell cycle contain twice the
amount of PI as 1n cells in the G1 phase of the cell cycle or resting G0 cells.
Cells with intermediate levels of PI are considered to be in the S phase.  65%
of Day 7 HSPC were 1n and were, thus, considered G0 or G1 phase (Figure
11C).  Cells containing twice the amount of DNA (i.e. 2n) were included in
HSPC cultures with 2% of Day 7 cells in G2/M.
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Figure 11. Flow cytometric cell cycle analysis of expanded HSPC (Day 7).  Live
cells (R1) were gated based on FSC and SSC (A). Single cells (R2) were gated
excluding cell aggregates resulting from fixation (B). Cell ploidy was determined based
on the stochastic integration of PI into HSPC DNA (C). Results from this experiment
demonstrate that following expansion 65% of HSPC were 1n (G0/G1) while 2% of
HSPC were 2n (G2/M). The remaining HSPC were in the S phase of the cell cycle
(33%). A representative analysis is shown.
Flow cytometric analysis was used to determine cell cycle status of
HSPC cultured in atmospheres containing physiological oxygen
concentrations.  No significant changes were noted between treatments after
1 day (Day 8) in the different oxygen concentrations.  When cell cycle status
was examined after 3, 5 and 7 days of culture, differences were seen.  The
greatest difference between treatments was measured on Day 12, following 5
day culture in physiological oxygen concentrations.  Culture of cells in both
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low oxygen atmospheres increased the number of G0/G1 HSPC, with
subsequent reductions in G2/M and S phase cells.  This effect was dose-
dependent with the greatest increases seen when cells were cultured in 1%
O2.  On Day 12, 92% of HSPC in 1% O2 were G0/G1 compared to 85% and
78% of HSPC in 8% and 21% O2, respectively.
These results demonstrate the effects of low oxygen on HSPC cell
cycle status.  Cell culture in atmospheres mimicking early placental
development resulted in a rapid increase in resting HSPC.  The percentage of
resting cells increased with time while the percentage of S/G2/M cells
subsequently decreased.  HSPC culture in a hyperoxic environment (21% O2)
also increased the percentage of resting HSPC, although not as rapidly as low
oxygen environments.
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Figure 12. Pie diagrams generated from HSPC cell cycle
analysis during culture in different oxygen concentrations.
HSPC were grown in 1%, 8% or 21% O2 and cell cycle status
determined on days 7, 8, 10, 12 and 14.  Low oxygen dose-
dependently increased the number of resting G0/G1 HSPC over the
test period. Subsequent reductions in cycling G2/M and S cells
were measured. Experiments were repeated 5 times;
representative data is shown.
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4.6 HSPC Apoptosis Analysis
Cell culture dynamics were further investigated utilising flow cytometric
quantification of HSPC apoptosis.  Cells were stained with Annexin V-FITC
and PI in order to distinguish live cells (Annexin V-PI-) from early apoptotic
(Annexin V+PI-) and late apoptotic/necrotic (Annexin V+PI+) cells (see Figure
7).  HSPC apoptosis was measured following expansion (Day 7).  HSPC were
then cultured in low oxygen (1% or 8% O2) or ambient oxygen (21% O2) and
apoptosis levels quantified on days 8, 10, 12, and 14.
Results from this experiment demonstrated that culture in physiological
oxygen concentrations had no significant effects on HSPC apoptosis levels.
Upon examination of individual experiments minor differences were noted.
For example, when compared to culture in ambient oxygen (21%), higher
levels of total apoptosis (early and late apoptosis) were measured after 7 day
culture in 1% O2 (Figure 13).  More importantly however, no significant
differences were noted when data obtained from multiple experiments (n = 3)
was compiled (Chart 4).
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Figure 13. Flow cytometric analysis of HSPC apoptosis.
Expanded HSPC (Day 7) apoptosis levels were quantified with flow
cytometry following staining with Annexin V-FITC and propidium
iodide (PI). Cells were subsequently cultured a further 7 days in 1%
or 8% O2 and analysis performed on days 8, 10, 12 and 14.
Apoptosis was similarly quantified during culture in ambient oxygen
(21% O2). Representative results from one of three experiments are
shown.
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Chart 4. Compiled HSPC apoptosis data following culture in 1%, 8% or 21% O2.
4.7 HSPC Characterisation During Low Oxygen Culture
4.7.1 Gene expression analysis
 Alterations in HSPC gene expression during incubation in
physiological oxygen concentrations were examined with RT-PCR.  cDNA
was synthesised from extracted total cellular mRNA and probed using
primers for various genes known to be expressed during hematopoietic and
endothelial cell development.
A representative non-quantitative RT-PCR analysis following seven-
day incubation of HSPC in low oxygen (1% or 8% O2) or atmospheric
oxygen (21% O2) is illustrated (Figure 14).  A variety of hematopoietic and
endothelial cell mRNA were expressed over the entire culture period.  HSPC
genes, including CD133, CD117, GATA-1 and -2, Runx-1 and SCL/Tal-1
were expressed in all conditions.  The expression of genes associated with
vascular development, such as VEGFR-1 and VEGFA165, were also
expressed in HSPC cultures.  Interestingly, expression of VEGFR-2 was not
seen in all HSPC cultures tested.   HSPC gene expression altered during
culture in physiological oxygen concentrations.  Alterations noted in gene
expression during RT-PCR analysis necessitated further characterisation of
HSPC at the protein level.
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Figure 14. Gene expression analysis of HSPC during culture in
low oxygen. Expression of specific hemangioblast genes during 7
day HSPC culture was examined with RT-PCR. The housekeeping
gene, β-actin was utilised as a control. Differentiated cells, such as
the HSPC negative (CD133-) fraction (D0), adult mononuclear cells
(MNC) isolated from peripheral blood and endothelial cells
(HUVEC), were concurrently examined. NA: results not available.
4.7.2 Protein expression analysis
The effect of simulated placental oxygen tensions on HSPC
differentiation was assessed with flow cytometry based on expression of CD
markers.  Expanded HSPC were cultured for an additional 7 days in HSPC-
GM in either atmospheric (21% O2) or physiological oxygen concentrations
(1% or 8% O2) and analysed with flow cytometry.  Flow cytometric analysis
was performed on Day 10 and Day 14.
As shown, the majority of expanded HSPC expressed CD45
(88%), an established marker for cells of hematopoietic lineages (Chart 5).
Coexpression of CD31 and CD140b was also examined in this investigation.
Chart 5 demonstrates the low coexpression of these markers on Day 7
HSPC; no change was seen during culture of HSPC in the various
conditions.
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Chart 5. Flow cytometric characterisation of HSPC following 7 day culture in
atmospheric oxygen (21% O2) or low oxygen (8% or 1% O2).
Day 7
- 21 8 1 21 8 1
CD45 87.56% 80.44% 87.58% 79.50% 87.83% 89.97% 83.99%
CD34/CD133 10.02% 4.13% 5.07% 4.30% 2.30% 2.42% 2.56%
CD34 27.28% 8.47% 11.80% 7.29% 5.56% 5.88% 3.21%
CD117 61.64% 50.93% 48.03% 28.09% 40.42% 32.31% 19.15%
CD31 71.49% 73.69% 76.14% 86.94% 73.11% 82.82% 83.98%
CD11b/CD14 0.65% 5.01% 10.66% 12.13% 12.78% 18.46% 22.92%
CD31/CD140b 0.53% 0.42% 0.50% 0.69% 1.44% 1.16% 1.44%
MARKER
HSPC CELL AGE (Days after isolation)
Day 10 Day 14
Culture Conditions (% Oxygen)
Coexpression of CD34, CD133 and CD117 distinguishes a subset of
multipotent stem cells. Therefore, expression of these HSPC stem cell
markers was examined with flow cytometry during culture (Chart 5 and
Figure 15).  In this investigation, approximately 12% of expanded HSPC
were CD34 and CD133 double positive (Figure 15A); approximately 11%
were CD133 and CD117 double positive (Figure 15B).  Culture of HSPC in
the tested conditions resulted in a decreased percentage of cells expressing
stem cell markers.  Day 10 HSPC were less than 5% CD34+CD133+ or
CD133+CD117+ regardless of the oxygen concentration.  By Day 14, less
than 3% of the cells were either CD34+CD133+ or CD133+CD117+ double
positive.
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Figure 15. Expression stem cell markers on HSPC during low
oxygen culture. Cells were gated and expression of stem cell
markers analysed. Approximately 12% of expanded HSPC (Day 7)
coexpress CD34 and CD133 (A). Approximately 11% of Day 7
HSPC coexpress CD133 and CD117 (B). Further culture in
atmospheric oxygen (21% O2) or in physiological oxygen (8% or 1%
O2) for 3 days (Day 10) and 7 days (Day 14) resulted in a
decreased percentage of HSPC stem cell marker coexpression.
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Another interesting result obtained following flow cytometric analysis of
HSPC cultured in physiological oxygen was seen when coexpression of
monocyte markers was analysed (Figure 16).  Multiparametric flow
cytometry allowed the examination of CD11b (αM integrin) and CD14
coexpression.  Double positive cells (CD11b+CD14+) were gated.
CD11b+CD14+ cells were contained within a population of cells coexpressing
CD31 (PECAM) and CD13.  Quadruple positive cells
(CD11b+CD14+CD31+CD13+) were considered monocytes.  HSPC cultures
expanded for 7 days consisted of 1% monocytes (Figure 16A).  HSPC were
then cultured for 1 week in a hyperoxic atmosphere (21% O2) or in
physiological oxygen concentrations (1% or 8% O2).  Media was changed
and flow cytometry performed on Day 10 and Day 14.  Figure 16B illustrates
representative results obtained on Day 14.  Day 14 HSPC cultures consisted
of 5% monocytes.  Low oxygen culture increased the percentage of
monocytes in HSPC culture.  Day 14 HSPC cultures grown in 8% or 1%
consisted of 8% and 11% monocytes, respectively.
These results illustrate the heterogeneity of HSPC cultures and
demonstrate the influence of simulating physiological oxygen environments
on the cells.  The expansion protocol used in this investigation was
demonstrated to maintain a population of CD133+CD34+CD117+
stem/progenitor cells.  At the same time, proliferation and differentiation of
cells resulted in an increase in differentiated cells (e.g. monocytes).  Cells
cultured in physiological oxygen concentrations (1% or 8% O2) also
maintained a population of HSPC and simultaneously increased
differentiation.  A significant difference was seen between oxygen
concentrations when CD11b+CD14+ monocytes were quantified.  Expression
of adhesion molecules, such as CD11b (αM integrin) and CD31 (PECAM)
also appear to be affected by low oxygen.
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Figure 16. Expression of monocyte markers on HSPC
cultivated in low oxygen.  Expanded HSPC (Day 7) were
incubated with fluorescently labelled antibodies against CD11b,
CD14, CD13, and CD31 and subjected to multiparametric flow
cytometry. Live cells (A) were gated based on size (FSC) and
granularity (SSC). Cells coexpressing CD11b and CD14
(CD11b+CD14+) were further gated. The majority of CD11b+CD14+
cells were contained within a population of CD31+CD13+ cells
(monocytes). On Day 7, <1% of cells expressed all four markers.
Cells expanded a further 7 days (Day 14) were similarly gated and
analysed (B). In atmospheric oxygen (21% O2), 5% of cells
expressed monocyte markers. The percentage of monocytes
increased with decreasing oxygen concentration (8% and 11% of
cells in 8% O2 and 1% O2, respectively).
4.8 HSPC Matrix Metalloproteinase Activity
The expression of matrix metalloproteinases (MMP) has been shown in
hematopoietic stem cells, as well as, differentiated monocytes and
macrophages.  In this investigation gelatine zymography was employed to test
whether culture in low oxygen altered HSPC collagenase (MMP-2 and MMP-
9) activity.  HSPC cultured for a total of 5 days in 1% or 8% oxygen and the
ability of HSPC-derived MMP to digest gelatine was tested.  Bands
corresponding to active 72 kDa MMP-9 and 49 kDa MMP-2 were apparent in
media conditioned by HSPC.  Culture of HSPC in decreasing oxygen
concentrations (1% and 8% O2) resulted in an increase in MMP enzymatic
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activity (Figure 17).  These results demonstrate that HSPC cultures in
simulated placental oxygen tensions increased their matrix-degrading ability,
suggesting a functional activity of mixed cultures consisting of HSPC and
differentiated hematopoietic cells.
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Figure 17. Gelatine zymography following HSPC culture in low
oxygen. MMP activity was assessed utilising gel containing 10%
gelatine. Secreted proteins present in HSPC-conditioned media
were first separated, followed by enzyme reactivation; bands
appear where reactivated gelatinases (MMP-2 and MMP-9)
digested collagen present in the gel. A representative gelatine
zymogram is shown (A). HSPC-CM collected during culture in low
oxygen concentrations (1% and 8 O2) contained active MMP-9.
Conditioned media from HSPC cultured in a hyperoxic environment
(21%) was included for comparison. Densitometry was performed
on individual zymograms (n = 5) and the data compiled (B). Bars
represent standard deviation.
4.9 Placental-Derived Factors Affect HSPC Number
Reducing in vitro oxygen concentration dose-dependently decreased
HSPC culture expansion in HSPC-GM (see Figure 10).  Treatment of HSPC
cultures with serum-free conditioned media from trophoblast-enriched (HTR)
and stroma-enriched (HPF) cell cultures in physiological oxygen
concentrations (1% or 8% O2) further decreased cell number (Figure 18).  Cell
number decreased slightly when HSPC were cultured in HPF-conditioned
media (HPF-CM).  Oxygen concentration had no significant effect on HSPC
proliferation in HPF-CM.  Incubation of HSPC in HTR-conditioned media
(HTR-CM) caused an initial decrease in cell number followed by an increase
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in HSPC cell number at Day 14.  In contrast to HPF-CM, oxygen
concentration had a significant effect on HSPC proliferation in HTR-CM - the
lower the oxygen concentration, the greater the HSPC number at Day 14.
Seven-day culture of HSPC in serum-reduced media (SRM) resulted in a
significant decrease in cell number.  Analysis of cell viability demonstrated
that culture with SRM greatly reduced HSPC viability.
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Figure 18. Placental-derived factors and oxygen affect HSPC
number.  HSPC (Day 7) were cultured with serum-reduced media
(SRM) or HSPC Growth Media (HSPC-GM) in ambient oxygen
(21% O2). HSPC were simultaneously cultured in low oxygen (1%
or 8% O2) with trophoblast-conditioned media (HTR-CM) or
placental stromal cell-conditioned media (HPF-CM).  HSPC number
was quantified on Days 10, 12, and 14. HSPC number was affected
by culture in HTR-CM and HPF-CM in low oxygen. The decrease in
cell expansion was greatest in 1% O2. On Day 14, cell number
increased when HSPC were incubated in HTR-CM (8% and 1%
O2). HSPC culture in SRM resulted in decreased cell number.
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These results demonstrate that culture of HSPC in conditioned media
from early human placental cells effects HSPC number.  HSPC proliferation in
trophoblast-enriched (HTR) conditioned media appeared to be affected by
oxygen concentration, while HSPC proliferation in trophoblast-deprived (HPF)
conditioned media was not affected by oxygen concentration.  Neither HTR-
nor HPF-CM could expand HSPC cultures as effectively as traditional
methods using HSPC-GM in ambient oxygen (21% O2).
4.10 Placental-Derived Factors Affect CXCR4 Expression on HSPC
Multiparametric flow cytometry was employed to examine CD11b and
CXCR4 expression on HSPC cells.  Live cells were first gated and isotype-
matched control antibodies used to exclude non-specific antibody binding.
The percentage of CD11b+CXCR4+ cells is highlighted (black box in top right
quadrant).
Flow cytometric analysis of CXCR4 expression after HSPC expansion
(Day 7) demonstrated that only 4% of CD11b+ cells expressed CXCR4 (Figure
19A).  Further 7 day expansion in ambient oxygen increased the percentage
of CD11b+CXCR4+ cells to 7% (Figure 19B).  In comparison, coculture of
HSPC with either placental stroma-enriched (HPF) or trophoblast-enriched
(HTR) cell cultures in low oxygen (1% and 8% O2) markedly altered CD11b
and CXCR4 protein expression (Figure 19C).  HSPC coculture with HTR or
HPF increased the percentage of CD11b+CXCR4+ cells to approximately
20%.  As shown previously in this report, decreasing oxygen tension in vitro
once again increased the percentage of CD11b+ monocytes in HSPC cultures
(see Figure 16).  Different expression patterns were noted between the
different cocultures.  As opposed to coculture with HTR, HSPC coculture with
HPF does not significantly alter the number of CD11b+ cells not expressing
CXCR4 (CXCR4-).  Results from this investigation demonstrate that, along
with oxygen, secreted factors present in the placental microenvironment can
have significant effects of HSPC phenotype.
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Figure 19. Flow cytometric analysis of CXCR4 expression of
expanded HSPC (Day 7) and following coculture with placental
cells (HPF and HTR) in low oxygen (1% and 8%). HSPC were
subjected to flow cytometric analysis following labelling with anti-
CD11b and anti-CXCR4 antibodies.  Plots represent gated live cells
and demonstrate the percentage CD11b+CXCR4+ HSPC (box
upper right). Day 7 HSPC were 3% CD11b+CXCR4+ (A). HSPC
were subsequently cultured for a further 7 days with HSPC-GM in
atmospheric oxygen (B) or cocultured with HTR or HPF in different
oxygen concentrations (C). When compared to standard HSPC
expansion protocol, coculture resulted in significant increases in the
percentage of CD11b+CXCR4+ cells with no significant differences
noted between oxygen concentrations.
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4.11 SDF-1α Expression in Human Placenta
Expression of SDF-1α mRNA and protein was investigated in human
placental tissue.  RT-PCR products from two experiments illustrate SDF-1α
mRNA expression in placenta (Figure 20).  Results from this experiment
clearly demonstrate that SDF-1α is expressed at the mRNA level in early
human placental tissue.  Expression of SDF-1α mRNA in term placental
tissue appears lower than in the first trimester, although direct quantitative
analysis was not possible.
Placental tissue
β-actin β-actinSDF-1α SDF-1α -RT
21
early term early term early term early term early term
Figure 20. SDF-1α mRNA expression in early and late placental
tissue.  RNA was extracted from placental tissue of various
gestational ages and probed with specific SDF-1α primers. Results
from two separate PCR are shown above (1 and 2). SDF-1α mRNA
was expressed in early human placental tissue. β-actin and
reactions not containing reverse transcriptase (-RT) were used in
these investigations as controls.
SDF-1α protein expression was seen throughout human placental
tissue in both trophoblast and chorionic villous stromal cells (Figure 21).  SDF-
1α expression was seen at all time points.  Strong SDF-1α expression was
noted in a trophoblast layer surrounding the chorionic villi in the earliest tissue
sample (6 wpc).  Furthermore, SDF-1α was expressed within the chorionic
villous stromal core along with the mesodermal cell marker, vimentin.  Anti-
SDF-1α antibodies stained cell clusters or cords in areas where developing
villous blood vessels are located in six-week old placental tissue.  At 12 wpc,
trophoblast and villous stromal cells continued to express SDF-1α protein.
Perivascular regions within the villous core also labelled with SDF-1α
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antibodies.  This pattern of SDF-1α expression continued throughout
gestation.  In term placental tissue (38 wpc), vascular structures within the
chorionic villi clearly remain SDF-1α positive.
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SDF-1α / Cytokeratin 7SDF-1α 
SDF-1α  / Vimentin SDF-1α  / Vimentin
B.  Early placenta (12 wpc)
SDF-1α SDF-1α / Cytokeratin 7
SDF-1α  / Vimentin SDF-1α / Cytokeratin 7
                 C.  Term placenta (38 wpc)
SDF-1 α / Cytokeratin 7SDF-1 α SDF-1 α / Vimentin
Figure 21. SDF-1α expression in human placental villous
tissue. Human placental tissue from 6, 12 and 38 wpc were
immunolabelled with anti-human SDF-1α (red). Trophoblast and
villous stromal cells were labelled with anti-cytokeratin 7 and
vimentin antibodies, respectively (both in green) and double-
positive cells can be seen in the merged images (yellow).
Multinucleate syncytiotrophoblast cells surrounding the villi
expressed SDF-1α at all time points. In the earliest tissue (6 wpc),
SDF-1α expression was also noted on vimentin-positive villous
stromal cells (A). Some double-positive cells appear in cell clumps
or cords. In later placental tissue (12 wpc), SDF-1α expression was
apparent in perivascular regions (B). Blood vessels stained positive
for SDF-1α in mature placental tissue (C). Original magnification
200X.
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4.12 Placental-Derived Cells Express SDF-1α In Vitro
RT-PCR and immunochemistry were once again employed to explore
expression of SDF-1α mRNA and protein.  Purified placental cells, including
trophoblast-enriched (HTR) and stroma-enriched (HPF) cell fractions, were
examined following 3 day culture in low oxygen (1% or 8% O2) or atmospheric
oxygen (21% O2).  Figure 22A illustrates results from a representative RT-
PCR using SDF-1α gene-specific primers.  Both HTR and HPF cell cultures
expressed SDF-1α mRNA after 3 day culture in a hyperoxic  (21% O2) or low
oxygen (1% O2) environment.  Consequently, immunocytochemistry was used
to investigate SDF-1α protein expression in placenta stromal cell-enriched
(HPF) fractions isolated from human first trimester placental samples.  HPF
cell cultures were incubated in either 1% or 8% O2 environments for 2 days
before being probed with monoclonal anti-human SDF-1α antibodies.  SDF-
1α expressing HPF cells (red) and HPF cell nuclei counter-stained with
Hoechst  (blue) can be seen in Figure 22B.  SDF-1α positive cell staining was
seen in when HPF cultures were incubated in either 1% or 8% O2.  Protein
expression patterns suggest cytoplasmic or extracellular expression.  HPF
cultures probed with mouse IgG1 were used to exclude non-specific labelling
of secondary antibodies.
These results demonstrate the expression of SDF-1α mRNA and
protein in stromal-derived cells isolated from first trimester human chorionic
villi.  In vitro SDF-1α protein expression was shown during culture in low
oxygen.
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Figure 22. Primary placental cell cultures express SDF-1α
mRNA and protein.  Trophoblast-enriched (HTR) or stroma-
enriched (HPF) were incubated for 3 days in 1% or 8% O2 or in a
hyperoxic environment (21% O2). Cellular mRNA was isolated and
probed for SDF-1α (A).  Expression of β-actin and reactions where
reverse transcriptase was excluded (-RT) were used controls. Both
HTR and HPF cultures expressed SDF-1α mRNA.
Immunocytochemistry was used to examine SDF-1α expression in
HPF cultures cultured in low oxygen (B). Fluorescently (PE)-
labelled secondary antibodies were used to recognise bound anti-
SDF-1α antibodies (red); cell nuclei were stained with Hoechst
(blue). Replacement of anti-SDF-1α antibodies with mouse IgG was
used as a control (Hoechst/IgG1). Original magnification 200X.
4.13 Placental Cells Secrete SDF-1α Protein
A highly sensitive SDF-1α immunoassay was utilised to determine
protein expression levels in media conditioned during culture with different
placental-derived cells.  Media collected from mixed first trimester placental
cell cultures in atmospheric oxygen contained approximately 2-fold more SDF-
1α than media conditioned by mixed term placental cells (Figure 23).
Likewise, conditioned media from primary and trophoblast tumour cell lines
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were analysed.  SDF-1α protein was secreted over a 24 h period into media
conditioned by both HTR and HPF cells (Figure 23).  However, secreted SDF-
1α protein was not detected in media conditioned by Jeg3 choriocarcinoma
cells.    Although SDF-1α protein was detected in conditioned media from
trophoblast-enriched (HTR) cell cultures (6.1 ± 0.1 pg/ml), the placental
stroma-enriched fraction (HPF) produced considerably greater levels of SDF-
1α under these conditions (452.2 ± 0.2 pg/ml).
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Figure 23. SDF-1α protein secretion by placental-derived cell
cultures.  Conditioned media was collected following 24-hour
incubation and secreted SDF-1α protein assessed utilising ELISA.
Media was conditioned during culture with mixed placental cell
cultures from early (8 wpc) or term placentas (37 wpc), Jeg3
choriocarcinoma cells, trophoblast-enriched (HTR) or placenta
stroma-enriched (HPF) cell fractions from first trimester placentas.
SDF-1α was produced and secreted by various placental cells with
the greatest SDF-1α production seen in media conditioned by HPF.
To examine whether in vitro oxygen level affected SDF-1α protein
secretion, placental stroma-enriched (HPF) cultures were incubated for 48 h in
low oxygen (1% and 8% O2) and conditioned media collected.  SDF-1α levels
were quantified (Figure 24).  HPF cultures in hyperoxic tissue culture
conditions (21% O2) were included for comparison.  Secretion of SDF-1α
protein into conditioned media was greatest when HPF were cultured in
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normal atmospheres (21% O2).  However, SDF-1α protein was also found
when HPF were incubated in physiological oxygen concentrations.  Media
conditioned by HPF in 8% O2 contained 895.3 ± 32.0 pg/ml SDF-1α protein;
conditioned media from HPF cultures incubated 48 h in 1% O2 contained
635.3 ± 42.0 pg/ml SDF-1α protein.
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Figure 24. SDF-1α protein secretion by chorionic villous
stromal cells (HPF) in low oxygen. ELISA measured secreted
SDF-1α protein in media conditioned during 48 h incubation with
HPF in low oxygen (1% or 8% O2) or atmospheric oxygen (21%
O2). The greatest amount of SDF-1α was secreted during HPF
culture in hyperoxic conditions (1059 ± 26 pg/ml). Lower levels of
SDF-1α were measured in media conditioned during culture in
simulated placental oxygen concentrations (635 ± 42 and 895 ± 32
in 1% and 8% O2, respectively). Standards and samples examined
in triplicate; error bars represent standard deviation. A
representative experiment is shown.
These results provide further evidence that cells in the developing
placenta express and secrete SDF-1α protein, suggesting a role for SDF-1α
during early placental development.  As demonstrated with RT-PCR,
immunochemistry and ELISA, placental stromal (HPF) cells express SDF-1α
protein.  In this model, HPF cells not only expressed SDF-1α in the hyperoxic
environment encountered during tissue culture, but also in simulated placental
oxygen concentrations found during early development.
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4.14 Placental-Derived Factors Stimulate HSPC Migration
HSPC in vitro migration was quantified with a modified Boyden
chamber assay.  In all experiments, migration of cells in serum-reduced media
(SRM) was considered basal HSPC migration.  When compared to basal
migration, addition of trophoblast-conditioned media (HTR-CM) to the assay
stimulated HSPC migration (Figure 25).  HTR-CM also stimulated migration
above levels induced by 50 ng/ml recombinant SDF-1α.  Treatment of HSPC
with placenta stromal cell-conditioned media (HPF-CM) also stimulated
migration above both basal levels and SDF-1α-induced levels.  No significant
differences were noted between HSPC migration towards HTR-CM or HPF-
CM.  This experiment demonstrates paracrine stimulation of HSPC migration
by both trophoblast and placenta stromal cells.  To assess SDF-1α
involvement in the stimulation of migration by HTR-CM or HPF-CM, the
specific CXCR4 inhibitor AMD3100 was included in the assay.  In this
investigation, AMD3100 was shown to inhibit SDF-1α stimulation of migration
as the combination of recombinant human SDF-1α and AMD3100 reduced
HSPC migration to basal levels.  Although no change was seen with the
combination of AMD3100 and HTR-CM, the CXCR4 antagonist did, in fact,
reduce HPF-CM stimulated migration.  This suggests the involvement of
placenta stromal-derived SDF-1α in the stimulation of HSPC migration in this
investigation.  However, SDF-1α does not appear to be the only chemotactic
stimulus in the developing placenta, as AMD3100 was unable to reduce
HSPC migration to basal levels.
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Figure 25. Effect of factors secreted by placental cells on
HSPC migration.  HSPC were cultured for 8 h and the ability of
HTR- or HPF-CM to stimulate migration quantified. Culture of
HSPC in the absence of all factors (SRM alone) was considered
basal migration. Wells containing 50 ng/ml SDF-1α were used as
positive control. The involvement of SDF-1α in the conditioned
media-stimulation of migration was examined by including the
specific CXCR4 antagonist, AMD3100. Treatments were performed
in triplicates; error bars represent standard deviations.  A
representative experiment is shown.
4.15 Placental-Derived Factors Stimulate HSPC Transendothelial
Migration
Further investigations determined whether placental stroma-derived
SDF-1α stimulated HSPC transendothelial migration.  Following 24 h
incubation in either 1% or 8% O2, HPF stimulated HSPC transendothelial
migration above basal levels (Figure 26).  Significant differences were not
seen between oxygen concentrations.  Similar levels of HSPC
transendothelial migration were seen when 50 ng/ml SDF-1α was included in
the assay.  Addition of 1 µg/ml AMD3100, along with HSPC to the upper well
of the migration chamber significantly decreased HPF-stimulated HSPC
transendothelial migration.  This suggests involvement of SDF-1α in the
induction of HSPC migration by HPF.  As shown for migration, blocking SDF-
1α - CXCR4 interactions with AMD3100 did not fully abrogate HPF stimulation
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of HSPC transendothelial migration, implying the involvement of other
placental-derived factors.
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Figure 26. Effect of placental stroma derived factors on HSPC
transendothelial migration.  Fluorescently labelled HSPC (PKH-
HSPC) were cultured for 12 h and their ability to migrate through a
HUVEC monolayer quantified. The ability of placental stromal
(HPF) cells incubated in 1% or 8% O2 to act as a migratory stimulus
was tested utilising coculture. Basal HSPC transendothelial
migration was considered the absence of all factors (SRM).
Addition of 50 ng/ml SDF-1α to the assay was used as positive
control.  Involvement of SDF-1α in the stimulation of migration was
examined by including the specific CXCR4 antagonist, AMD3100.
Treatments were performed in triplicates; error bars represent
standard deviations. A representative experiment is shown.
4.16 HSPC Adhesion to Placental Stromal Cells Involves SDF-1α
Coculture of fluorescently labelled HSPC with various placental-derived
cells was utilised to determine whether HSPC adhered to the various cellular
components present in developing human placenta.  HSPC adhered to mixed
placental cells isolated from early human placental tissue (8 wpc), Jeg3
choriocarcinoma cells, trophoblast-enriched (HTR) and stroma-enriched cells
when cocultured 48 h in a hyperoxic environment (Figure 27).  Relative
adhesion varied among the tested cell fractions.  Minimal cell-cell adhesion
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was measured when HSPC were cocultured with either mixed cells from early
placenta (8 wpc) or Jeg3 cells.  A significant increase in adhesion was seen
when trophoblast-enriched HTR cells were included in the assay.  The
greatest cell-cell adhesion was measured when HSPC were cocultured with
placental stroma cells (HPF).  In fact, relative adhesion of HSPC to HPF in
normal tissue culture conditions was greater than 2-fold when compared to
HSPC adhesion to HTR.
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Figure 27. HSPC cell-cell adhesion to placental-derived cells.
Fluorescently labelled HSPC were cocultured for 6 h with mixed
placental cells, Jeg3 choriocarcinoma cells, HTR or HPF. Following
coculture, nonadherent cells were removed and number of
adherent HSPC quantified utilising flow cytometry. HSPC adhesion
to wells containing no additional cells (plastic alone) was set to 1
and relative adhesion shown. HSPC adhered to all cell cultures
tested, although the greatest level of cell-cell adhesion was seen
during HPF coculture. Treatments were performed in triplicate; error
bars represent standard deviation. A representative experiment is
shown.
The effect of low oxygen on HSPC adhesion was also investigated.
The greatest number of HSPC adhesion to HTR was seen when cocultures
were performed in 1% O2 (Figure 28), demonstrating that physiological
oxygen has a positive effect on HSPC adhesion to trophoblast.  In fact, the
level of relative adhesion of HSPC to HTR in 1% O2 was similar to HSPC-HPF
adhesion.  In 8% O2, HSPC also adhered to HTR.  AMD3100 did not
significantly reduce relative HSPC-HTR adhesion.  On the contrary, adhesion
of HSPC to HPF was not affected by oxygen concentration.  Furthermore,
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addition of AMD3100 decreased the relative adhesion of HSPC to placental
stroma cells, implicating SDF-1α involvement during HSPC adhesion to
placental stromal cells.
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Figure 28. HSPC cell-cell adhesion with placental-derived cells
(HTR or HPF) in low oxygen (1% or 8% O2).  Fluorescently
labelled HSPC were cocultured for 12 h in the appropriate oxygen
concentration (1% or 8% O2) with HTR or HPF. Following coculture,
non-adherent cells were removed and number of adherent HSPC
quantified utilising flow cytometry. HSPC adhesion to wells
containing no additional cells (plastic alone) was set to 1 and
relative adhesions shown. HSPC adhesion to trophoblast cells
appeared to be affected by oxygen concentration with the greatest
HSPC-HTR adhesion seen in the lowest oxygen concentration (1%
O2).  SDF-1α did not appear to play a role in adhesion of HSPC to
HTR as no significant change was noted when the CXCR4 inhibitor
AMD3100 was included in the assay.  HSPC adhesion to HPF cells
was not affected by oxygen concentration. AMD3100 significantly
reduced HSPC adhesion to HPF. Treatments were performed in
triplicate; error bars represent standard deviation. A representative
experiment is shown.
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4.17 HSPC Integrin Expression is Altered in Low Oxygen
Alterations in HSPC adhesion (see Figure 28), as well as, changes in
CD11b (αM integrin) expression (see Figure 16) suggested that HSPC integrin
expression was affected during culture in low oxygen.  As previously
demonstrated, the expression of αM integrin subunit (CD11b) increased when
HSPC were cultured 7 days in simulated placental oxygen tensions (Figure
29); αM expression was greatest in environments containing 1% O2.  More
than 75% of HSPC expressed the β2 subunit.  No significant differences in β2
expression were noted between oxygen treatments.  Expression of α4 subunit
was also affected during culture in low oxygen environments. Conversely, 7
day culture of HSPC in 8% O2 resulted in a greater increase in α4 integrin
expression when compared to HSPC cultured 1% O2.  Almost all HSPC
expressed the β1 subunit with no differences noted between oxygen
concentrations.
αM α4 β1β2
1% O2
32%
8% O2
77% 33% 97%
21% 76% 45% 98%
Figure 29. HSPC integrin expression following culture in low
oxygen. HSPC were cultured for 7 days in low oxygen (1% or 8%
O2) and the expression of αM, α4, β1 and β2 integrin subunits on Day
14 examined with flow cytometry. Percentages in top right corner
illustrate positive cells. Dotted lines represent the appropriate
isotype controls.
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5 DISCUSSION
Current understanding of the development of the human feto-placental
vascular system is based, almost exclusively, on descriptive structural and
immunohistochemical studies.  In vitro approaches are under-represented due
to problems inherent to the placenta, such as ethical limitations and limited
availability of early human placental tissue.  Likewise, the recent suggestion
that the human placenta constitutes a stem cell niche has not attracted much
attention, possibly due to the same inherent problems.  We describe a novel
in vitro examination of the human placenta as a HSPC niche.  The impact of
oxygen and the involvement of SDF-1α during establishment of the placental
niche were specifically examined.
5.1 The Human Placenta as a Stem Cell Niche
Hematopoietic cells develop in the embryo in several anatomic
locations.  Co-ordinated hematopoietic sites ensure both rapid production of
differentiated blood cells for immediate needs and establishment of a large
pool of undifferentiated stem cells.  Hematopoiesis is first observed in the
human yolk sac at day 18.5 of pregnancy (Palis and Yoder, 2001).  The sites
of human hematopoiesis then change throughout embryogenesis and a
dogma exists that considers the linear movement of definitive HSC from the
aorta-gonads-mesonephros (AGM) region to the fetal liver and finally the bone
marrow (BM).  However, the ability of the yolk sac and AGM to supply all HSC
in the fetal liver has been questioned and the contribution of yet another
source of HSC has been suggested (Tavian et al., 2001).
The first evidence of transplantable hematopoietic activity in murine
placenta can be found in early transplantation studies by Till and McCulloch
(1960) and Dancis and colleagues (1968, 1977).  The ability of placental cells
to contribute to recipients’ hematopoiesis was similar to adult BM, was not
dependent on continuous blood supply to placenta and ceased by the end of
gestation.  These exciting findings in mice were not actively followed up until
recently.  In 2003, it was demonstrated that the mouse placenta contains
multi-potential clonogenic progenitors before colonisation of the liver is
initiated (Alvarez-Silva et al., 2003).  The most recent evidence has shown
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that mid-gestation murine placenta harbours a large pool of HSC with the
capacity to self-renew and repopulate the entire hematopoietic system of
irradiated mice (Gekas et al., 2005; Ottersbach and Dzierzak, 2005).  No
signs of hematopoiesis were seen before mesodermal cells originating from
the extra-embryonic allantois has fused to the chorionic plate.  It is difficult
however, to directly relate events during murine placentogenesis to humans
as placental development between both species differs significantly.
Some of the first cytological evidence for the appearance of HSC in the
human placenta were described using transmission electron microscopy
(Demir et al., 1989).  The structure of early placental tissue was examined and
the appearance of hematopoietic cells in the earliest stages of placental
development was demonstrated; expression of HSC markers was not
examined.  More recently, Challier et al. (2005) provided immunocytological
evidence for hematopoiesis in one month-old human placental tissue.  Near
the end of the first month (25 dpc) typical figures of hematopoiesis,
comparable to those described for the yolk sac of the human embryo, were
seen.  At this time point, placental tissue did not contain cells expressing the
hematopoietic marker CD45.  Similar results were shown in human placental
tissue at 6-7 wpc.  By the end of the first trimester (12-14 wpc), CD45+ cells
could be found in the human placenta.  The expression in early of early
markers of primitive and definitive hematopoiesis, such as GATA-2 and
CD117 (c-kit), further supported the concept of early placental hematopoiesis.
It was also stated that anti-CD34 antibodies did not stain chorionic villi at early
time points.
CD34 is a marker for HSPC and is commonly used during the isolation
of both hematopoietic stem cells and endothelial progenitor cells (Peichev et
al., 2000; Pomyje et al., 2003).  In this investigation, approximately 90% of
freshly isolated HSPC expressed CD34.  Immunohistochemistry also
demonstrated that the chorionic villous stroma from six-week old human
placental tissue contained CD34+ cells.  At this early developmental time
point, placental vascular development has been underway for approximately
three weeks (Demir et al., 1989).  Previous reports have also used CD34 to
distinguish early vascular cells in the developing placenta (Challier et al.,
2004; te Velde et al., 1997).  Thus, immunohistochemical investigations
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utilising only CD34 as a marker for HSPC, as reported here, cannot clearly
distinguish between HSPC and early vascular cells.  Coexpression of other
specific HSPC markers is needed.  In this investigation, the use of anti-CD133
antibodies to probe for HSPC in placental tissue was excluded due to
previous reports that trophoblast also express this marker (Potgens et al.,
2001).  Attempts to examine the coexpression of other HSPC markers in early
human placental tissue were also unsuccessful due to problems, such as non-
specific labelling of the available antibodies (e.g. CD117).  It would also be of
great interest to examine earlier tissue (i.e. >6 wpc) for the appearance of
progenitor cells, although the lack of tissue samples prohibited this in our
investigation.
5.2 Human Placental Development in Low Oxygen
Placental tissue is plastic and changes constantly throughout gestation
to meet and supply the increasing metabolic needs of the growing fetus.  The
stem cell-rich blastocyst begins as a trophectodermal cell layer surrounding
the inner cell mass.  After implantation, the human placenta reaches its
terminal size short after the end of the first trimester (12 wpc).   During this
initial period of rapid placental growth, oxygen tensions remain strikingly low.
Measurements made with polarographic electrode probes demonstrated that,
in the intervillous space prior to 8 wpc, pO2 is less than 20 mmHg; after 12
wpc placental pO2 is greater than 50 mmHg (Rodesch et al., 1992; Jauniaux
et al., 1999; Jauniaux et al., 2001).
Although the first trimester pO2 appear quite low, they represent normal
values in uncomplicated pregnancies and are relevant for that location and
time of development (Charnock-Jones et al., 2004; Kaufmann et al., 2004).
Therefore, in vitro models should take into account normal physiological pO2
present during placental development.  Concurrent measurements acquired in
this investigation during culture of both HSPC and placental cells clearly
demonstrate that normal placental oxygen tensions found during placental
development can be effectively mimicked in vitro.  The use of two different gas
mixtures, containing either 1% oxygen or 8% oxygen (5% CO2), simulated in
vivo oxygen tensions with surprising precision.  Measurements made here
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also clearly demonstrate that traditional cell culture in atmospheric oxygen
(21% O2) results in a hyperoxic environment with oxygen tensions well above
normal pO2 found in human tissues (157.9 ± 9.2 mmHg).
The use of low oxygen gas mixtures is not novel in placental research
as oxygen reduced environments have previously been used to assess
trophoblast development and function (Genbacev et al., 1997; Graham et al.,
1998; Caniggia et al., 2000).  One important difference, however, is that
previous investigations did not include real-time oxygen monitoring.  As clearly
demonstrated in this investigation, oxygen concentrations in low oxygen cell
culture systems are in a constant flux and are difficult to maintain at
physiological levels.  Accordingly, standardisation of experimental parameters
(e.g. cell number, media depth and composition, gas replacement intervals,
etc.) and extensive testing was required to ensure that actual physiological
oxygen concentrations were reached and then maintained.  Using
standardised protocols, variability between experiments was reduced.
Furthermore, and as opposed to previously published results, the SDR
oxygen monitoring system provided reliable data concerning in vitro oxygen
levels during the entire experimental period.
5.3 Low Oxygen Affects HSPC Culture Dynamics
Although tissue culture in 21% oxygen is most frequently used, there is
a growing body of evidence suggesting that the use of physiological oxygen
levels during cell culture provides a better picture of what is occurring in vivo.
The effects of low oxygen on cell proliferation and cell cycle kinetics has been
previously studied and the results appear to vary depending on oxygen
concentration and cell type (reviewed by Csete, 2005).
The exact composition of the media used during in vitro HSPC culture
varies among different laboratories and a lack of consensus exists as to which
factors are essential to maintain stem cell number while inhibiting
differentiation.  In our laboratory, the HSPC culture media consisted of IMDM
(10% FCS) supplemented with TPO, SCF, and Flt3L (HSPC-GM).  This
particular composition has been previously shown to maintain HSC in culture
(McGuckin et al., 2004; McGuckin et al., 2005).  Previous publications from
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our laboratory have also shown that HSPC culture in ambient oxygen with
HSPC-GM results in extensive expansion of HSPC cultures and can maintain
cultures for >60 days as assessed by trypan blue exclusion (Baal et al., 2004).
In this report, culture with HSPC-GM likewise stimulated HSPC proliferation in
21% oxygen during a seven-day proliferation assay.  Results from this assay
also demonstrated that when HSPC were cultured in physiological pO2 cell
proliferation was lower.  Decreased HSPC culture expansion in low oxygen
was dose-dependent with the greatest decrease noted when cells were
cultured in oxygen concentrations that mimicked early placental development
(1% O2).  The use of a Casy® Counter for this particular proliferation assay
allowed cell death to be concurrently assessed; low oxygen did not result in
significant alterations in HSPC cell death.
Similar results have been previously described.   Using CD34+ cells
isolated from adult peripheral blood, Ivanovic and colleagues (2000a, 2000b)
have demonstrated that HSPC proliferation was reduced in 1% oxygen.
Decreased HSPC culture expansion did not occur at the expense of
progenitor cell self renewal.  In fact, cd34 mRNA processing and CD34 protein
expansion was enhanced in low oxygen environments (Brunet et al., 2006).  It
was therefore suggested that the enhanced proliferation of HSC in low oxygen
may, in part, reflect the normal relatively low oxygen environment of stem cells
in their in vivo environment – the adult BM.  Models of marrow architecture
suggest that HSC normally reside in a low oxygen niche (Chow et al., 2001).
Delayed proliferative senescence in low oxygen environments with a
concurrent reduction in oxidative DNA damage could play a role, although
further investigation is needed.
Removal of cells from active cell cycling results in decreased cell
proliferation and thus, the transition of cells from G1/M/G2 to the G0 phase
can decrease cell number.  In the case of HSC, the most primitive stem cells
have been shown to be in the resting state (i.e. G0) with a G1/S progression
representing a developmental switch between HSC self-renewal and
differentiation (Szilvassy et al., 2000; Thornley et al., 2001; Stein et al., 2004).
Results in this report demonstrated the effect of placental oxygen tensions on
HSPC cell cycle status, where low oxygen rapidly increased the percentage of
G0 HSPC.  The rapid increase in the number of resting HSPC seen in
81
placental oxygen concentrations may be partially responsible for the dose-
dependent decreases seen in HSPC culture expansion.  It is logical to
assume that the quicker cells remove themselves from active cycling,
decreases in HSPC number would increase over time.  In fact, a lower cell
number was seen following seven-day culture in 1% oxygen.
Cell death is another factor when determining cell number.  The toxic
effects of oxygen and more specifically, reactive oxygen species (ROS) on
HSC are well described (Ito et al., 2004; Ito et al., 2006).  It has even been
suggested that ROS may be a major factor driving cellular ageing (Harman,
1956).  In our system, HSPC culture in hyperoxic environments did not
significantly stimulate apoptosis.  HSPC apoptosis was apparently unaffected
by low oxygen culture.
The impact of physiologically low oxygen on HSPC dynamics has been
demonstrated in this investigation.  When different placental oxygen levels are
simulated in vitro, HSPC transition to resting stem cells occurs.  Over time,
this results in a reduction of total HSPC number without significantly affecting
cell death and/or apoptosis.  These results provide further proof that culture of
HSPC in physiologically relevant oxygen concentrations can better recreate
their in vivo environment, perhaps providing a better picture of HSPC
dynamics in the stem cell niche.
5.4 HSPC Differentiation in Physiological Oxygen Concentrations
Oxygen has known effects on the regulation of gene expression.  In
this report the expression of specific genes was examined to determine
whether the culture conditions tested had any effects on HSPC differentiation.
The genes examined here were chosen due to their involvement in both
hematopoiesis and vascular development.  In fact, their expression has been
noted in the hemangioblast - a common precursor during hematopoietic and
endothelial cell development (Choi et al., 1998; Chung et al., 2002; Lacaud et
al., 2002).  It must be noted, however, that the non-quantitative nature of the
RT-PCR results did not allow for solid conclusions to be made about
expression levels.  Thus, the results obtained from PCR were used simply as
a guide for gene expression and to provide clues for changes in HSPC
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differentiation.  The alterations noted in during HSPC culture in physiological
oxygen levels suggested that low oxygen effects HSPC differentiation.  These
results also suggested that a further examination of HSPC differentiation,
through the quantification of protein expression, was necessary.
Recent reports have demonstrated that culture in low oxygen can help
maintain pluripotency, a key feature of stem cells.  For example, it is well
known that ES cells cultured in atmospheric oxygen tend to differentiate
spontaneously.  However, when ES differentiation was monitored in low
oxygen (3% or 5% O2), cells expressed pluripotency-associated genes (e.g.
Oct4) and the expression of differentiation-associated genes and proteins was
reduced (Ezashi et al., 2005).  Furthermore, the ability of murine HSPC to
repopulate bone marrow was enhanced when HSPC were cultured in 1% O2
(Ivanovic et al., 2000a).  In all conditions tested, the percentage of cells
expressing stem cells markers decreased over the seven-day period.  This is
not so unexpected when considering the increases in HSPC cell number due
to cell proliferation.  Thus, a decrease in the percentage of HSPC expressing
the stem cell markers may represent dilution of the stem cells pool. It was
shown that the CD133+CD34+ and CD133+CD117+ populations were
maintained over the entire culture period.  Surprisingly, no significant changes
in HSPC marker expression between treatments were shown.  Further
investigations are needed to determine whether HSPC cultured in low oxygen
(1% and 8% O2) or hyperoxia have different functional clonogenic potential or
repopulation abilities.  Such studies were beyond the scope of this
investigation.
Sustaining a balance between self-renewal and differentiation is
another inherent property of stem cells.  During culture in physiological
oxygen tensions the HSPC pool was maintained with a relatively constant
number of cells continuing to express known stem cell markers while
undergoing low levels of proliferation.  Nonetheless, increasing cell number
suggested that a population or populations of HSPC were undergoing
differentiation.
Consistent with a major role for hypoxia in vasculogenesis and
angiogenesis, a large number of genes involved in different steps of
angiogenesis are independently responsive to hypoxia in tissue culture. The
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effect of hypoxia on the vascular endothelial growth factor (VEGF) axis has
received special interest in diverse fields such human development and
tumour biology.  Most of these studies have focussed on hypoxia-inducible
factor (HIF-1)-1α, a transcriptional activator that functions as a master
regulator of cellular and systemic oxygen homeostasis.  Low oxygen stabilises
HIF-1α, which in turn drives expression of VEGF, VEGF receptor-1 (VEGFR-
1; a.k.a. Flt-1) and a VEGF isoform, placental-derived growth factor (PlGF).
Thus, the influence of hypoxia on endothelial progenitor cells and endothelial
cells has been well established.  CD34+ cells coexpressing VEGFR-2 and the
HSPC marker CD133 have been isolated from human peripheral blood, UCB
and fetal liver (Miraglia et al., 1997; Gallacher et al., 2000).  Circulating
CD133+ cells can even be differentiated to endothelial progenitor cells (EPC)
in vitro (Peichev et al., 2000; Quirici et al., 2001; Loges et al., 2004).  In fact, it
has been shown that in vitro hypoxic culture of EPC isolated from peripheral
blood enhanced therapeutic angiogenesis (Akita et al., 2003). In this
investigation, analysis of angioblast and HSC gene expression, such as
VEGF, VEGFR-1 and -2, provided no clear pattern.  Also, flow cytometric
analysis showed no effects on protein expression when HSPC were cultured
in low oxygen (data not shown).  Several possible explanations exist for these
apparent discrepancies.   Many of the above mentioned reports involved long-
term culture (>1 month) in differentiation media containing a variety of
recombinant growth factors.  HSPC utilised in this report, on the other hand,
were included in assays following short-term culture (≤ 1 week) in exapansion
media (i.e. HSPC-GM).  Other reports used cells differentiated from the entire
mononuclear cell pool present in peripheral blood.  It remains possible that
different cell populations were used.  On the other hand, it is plausible that the
complex processes of vasculogenesis and angiogenesis require specific cell
populations at different sites and different developmental stages.
While no affects on endothelial markers could be demonstrated, HSPC
expression of monocyte-associated proteins during culture in low oxygen was
significantly affected.  Freshly isolated and expanded HSPC cultures
contained less than 1% monocytes, as quantified with multiparametric flow
cytometry.  Incubation of HSPC in low oxygen dose-dependently increased
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the percentage of monocytes.  The functional importance of monocyte
differentiation in low oxygen remains unclear.  Multiple cell types are required
in the placental niche.  Some may act as accessory cells thereby helping to
provide a receptive niche for other cells directly involved in placental
vasculogenesis and/or angiogenesis (i.e. hemangioblast).
5.5 Extracellular Matrix Degradation in the Placental HSPC Niche
Extracellular matrix (ECM) degradation is involved in a variety of
cellular functions and is primarily mediated by the matrix metalloproteinases
(MMP).  It has been shown in murine tumour models that the majority of
CD11b positive hematopoietic cells located around blood vessels express
active MMP-9 (Takakura, 2006).  Inhibition of the gelatinases MMP-2 and -9
reduces the homing of CD34+ cells from UCB (Janowska-Wieczorek et al.,
2000).  Along with their involvement during invasion, MMP have been
suggested to play a role in releasing matrix-bound growth factors and
chemokines into the microenvironment (Condeelis and Pollard, 2006).
Growth factors such as SCF, VEGF and PlGF, as well as the chemokine SDF-
1α are known to bind to various components of the ECM.  Naturally,
degradation of the ECM and release of these factors into the
microenvironment could have direct effects on formation of blood vessels.  We
have demonstrated the secretion of active MMP-9 into media conditioned
during HSPC culture with an increase in MMP-9 activity seen in low oxygen
concentrations.  These data could represent an increase in functional activity
subsequent with the induction of monocyte differentiation.  However, the cell
type responsible for MMP production remains unclear and future experiments
must clarify the source of increased gelatinase activity to fully understand the
effects of increased MMP-9 in the placental microenvironment.
5.6 HSPC Home to Hypoxia
One obvious question that arises is how a discrete population of cells
specifically traffics to hypoxic areas to take part in new blood vessel formation
and growth.  Are specific factors involved in homing progenitor cells to areas
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where they are needed?  It is known that endogenous factors home HSC to
their niche in adult bone marrow.  It remains plausible that similar regulatory
mechanisms during developmental HSPC trafficking as well as following
injury.
The chemokine SDF-1α has been shown to be critical for homing stem
cells expressing the specific receptor CXCR4 to the bone marrow.  Studies of
mutant mice with targeted gene disruption have revealed that SDF-1α-CXCR4
signalling is essential for bone marrow colonisation by HSC during ontogeny
(Nagasawa et al., 1996; Kawabata et al., 1999; Zou et al., 1998).  Lethality
caused by SDF-1α or CXCR4 gene ablation prevents immediate analysis of
their role in adult hematopoiesis and angiogenesis.  None of the described
abnormalities, however, adequately explains the nearly uniform late
gestational lethality in the SDF-1α or CXCR4 null mice.  Knock-out placental
tissue has not yet been investigated (personal communication with
Nagasawa, T.).  Among the environmental signals in these tissues that may
be involved in recruiting cells is hypoxia.
In murine bone marrow, SDF-1α has been shown to maintain HSC in
their low oxygen niche (Sugiyama et al., 2006).  Hypoxia may even play a role
in the molecular regulation of SDF-1α and/or CXCR4 expression, although
results remain relatively unclear (Hitchon et al., 2002).  In ischemic tissue,
SDF-1α expression is localised to cells in the vascular microenviroment and
acts as a signal to facilitate human HSPC adhesion (Peled et al., 2000).
Ceradini and colleagues (2004; 2005) have also demonstrated the recruitment
of CXCR4+ murine HSPC to regenerating tissue is mediated by hypoxic
gradients via HIF-1α-induced expression of SDF-1α.
5.7 SDF-1α in the Human Placenta
As an endocrine organ, cells in the chorionic villi produce a large
number of growth factors, hormones and chemokines; these factors can have
autocrine and paracrine effects on placental cells (McKinnon et al. 2000;
Liang et al., 2004; Zygmunt et al. 2005; Herr et al. 2007).  Placental-derived
factors are also intricately involved in development and maintenance of the
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placental vasculature tree (Zygmunt et al., 2003).   Ubiquitous angiogenic
factors, such as VEGF-A and Angiopoietin (Ang)-1 and -2 have been shown
to be locally produced in the developing placenta and implicated in both
placental vasculogenesis and angiogenesis (Geva et al., 2002).  The placenta
is also a rich source of PlGF, which has been shown to exert effects on
endothelial cells at the fetomaternal interface (Zhou et al., 2003).   A
combination of both VEGF and PlGF at hypoxic sites can recruit progenitor
cells to sites of neovasculogenesis (Li et al., 2006).
Chemokines may also play an important role in placental development.
In vitro expression of SDF-1α and CXCR4 has been previously shown in
human placenta, although analysis of expression patterns concentrated
primarily on trophoblast cells (Ishii et al., 2000; Wu et al., 2004).   In the
human placenta, SDF-1α, by signalling through CXCR4 has been
demonstrated to stimulate anti-apoptotic pathways in isolated trophoblast cells
(Jaleel et al., 2004).  Results shown in this report illustrate SDF-1α mRNA and
protein expression in early placental tissue isolated from both 6 week-old and
12 week-old pregnancies.  At the mRNA level, SDF-1α expression was noted
in all early (≤12 wpc) placental tissue samples tested.  On the other hand,
although most term tissue samples contained SDF-1α mRNA, gene
expression was not seen in all tissue examined.  Different temporal
expression patterns cannot be ruled out.  Early placenta exists in a low
oxygen environment and SDF-1α has been shown, in some cells, to be
regulated by oxygen.  Therefore, decreased SDF-1α expression would be
expected in term placenta due to the fact that oxygen tensions are higher.
However, it is possible that different SDF-1α expression patterns in term
placenta also represent patient-specific differences or differences between the
actual tissue samples as tissue samples excised for mRNA isolation consisted
of different quantities of placental cells.  In situ SDF-1α protein expression
was noted in a variety of locations in developing chorionic villi as well as in
term placental tissue.  In support of the hypothesis that SDF-1α plays a role in
early placental blood vessel development, vimentin-positive villous stroma
cells also expressed SDF-1α, with strong expression seen at sites of vascular
development.  SDF-1α expression patterns continued until the end of
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pregnancy.  The presence of SDF-1α protein in placental tissue provides the
first suggestion that this chemokine may play a role in the developing
chorionic villous niche.
5.8 SDF-1α Secretion by Human Placental Cells In Vitro
It is known in the field of placentology that human trophoblasts are
notoriously difficult to isolate and maintain in culture.  The difficulties
associated with obtaining early placental material, the variety of trophoblast
cell types and a lack of trophoblast specific markers have also hindered
research.  In our laboratory, a novel method has been used to isolate
trophoblast-enriched cell fractions from early placental tissue (Baal, N. et al.
manuscript in preparation).  Trophoblasts are unique epithelial cells (Bischof
and Irminger-Finger, 2005).  Thus, microbeads coated with the epithelial-
specific cell adhesion molecule (Ep-CAM, also known as CD326) were used
to isolate a trophoblast-enriched cell fraction from enzyme-digested human
abortus material.  Isolated cells were shown to express the pan-trophoblastic
marker, cytokeratin 7, and to behave like trophoblasts in vitro.  CD326+ cells
consisting of a trophoblast-enriched cell fraction were called HTR.  On the
other hand, the CD326-negative fraction, consisting of the placental stroma-
enriched cell fraction, was used as a cellular model for the chorionic villi.  This
particular cell fraction contains cells expressing the mesenchymal marker
vimentin and was called HPF.  Both HTR and HPF have recently been used in
our laboratory in an in vitro model of human placenta.
 In vitro expression of SDF-1α was subsequently analysed in different
placental cells.  SDF-1α mRNA expression was demonstrated in both HTR
and HPF during culture in 1% oxygen or in hyperoxia (21% O2) with no
differences seen between treatments.  Media conditioned by different
trophoblast cell models (Jeg3 and HTR) during a 24 h culture period
contained only minimal amounts of SDF-1α protein, demonstrating that villous
trophoblast cells do not secrete significant amounts of SDF-1α protein.
Conversely, placental stroma-enriched cell fractions were shown to secrete
large amounts of SDF-1α protein in 1%, 8% and 21% oxygen.  Reducing
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oxygen concentration decreased SDF-1α secretion from HPF cells.  These
results were puzzling due to previous reports suggesting that hypoxia HIF-1α
regulates expression of SDF-1α in synovial fibroblasts (Hitchon et al., 2002).
The reasons for these discrepancies remain unclear, however, they may
represent differences between cell types.  This report first describes SDF-1α
secretion by placental stromal cells.  Future molecular and cellular
experiments will be required to determine the mechanisms involved during
SDF-1α expression in the human placenta.  These results provide further
proof that this particular chemokine is part of the milieu of factors present in
the developing human placenta.
5.9 Secreted Placental Factors Affect HSPC CXCR4 Expression
Intense interest in HSC research has provided a body of evidence
supporting a role for paracrine regulatory mechanisms in regulating stem cell
development and maintenance.  Development of hematopoietic cells is
regulated by hematopoietic growth factors, cytokines and chemokines
secreted by accessory cells (e.g. fibroblasts, endothelial cells, macrophages
and osteoblasts) residing in the various HSC microenvironments (reviewed in
Janowska-Wieczorek et al., 2001).  Bone marrow, as the adult HSC niche,
has been the most extensively studied, however new evidence emphasises
the need to determine whether similar paracrine regulatory mechanisms are
involved extra-embryonically.
For SDF-1α to induce a response, HSPC must express the appropriate
receptor.  CXCR4 is a novel chemokine receptor due to its SDF-1α specificity.
Cell trafficking in the hematopoietic and vascular systems involves specific
progenitor cell populations expressing CXCR4 (Ceradini and Gurtner, 2005).
Previously published data has shown that >5% of CD34+ cells isolated from
peripheral blood are also positive for CXCR4 (Yamaguchi et al., 2003).
Results from our investigation were in accordance with this data, where 4% of
expanded HSPC expressed CXCR4.
An accessory role for monocytes / macrophages during angiogenesis
has been previously described and CD11b+CD14+ monocytes have been
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shown to express proangiogenic factors, such as VEGF and Ang-1 (Rehman
et al., 2003).  Furthermore, monocyte-derived macrophages can support
tumour angiogenesis through their matrix-degrading capacities, growth factor
synthesis and engulfment of apoptotic cells (Condeelis and Pollard, 2006).
Therefore, low oxygen-induced HSPC differentiation to monocytes in the
placenta could also provide angiogenic support.  SDF-1α, as a chemotactic
stimulus, could then position monocytes in areas of blood vessel
development.  In fact, coculture of HSPC with both HTR and HPF cells
increased the percentage of CD11b+CXCR4+ cells over a seven-day period in
low oxygen.  Further experiments will be needed to determine the involvement
of CXCR4+ monocytes during placental vascular development.
5.10 HSPC Migrate in Response to Placental-Derived SDF-1α
A mechanism is needed to stimulate movement of progenitor cells into
position around developing blood vessels.  In a tumour model, Grunewald and
colleagues (2006) demonstrated the involvement of SDF-1α in positioning
progenitor cells around developing blood vessels.  Likewise, Kaplan and
colleagues (2005) illustrated the involvement of SDF-1α in positioning
progenitor cells in a pre-metastatic niche.  In the placenta, multiple factors
have been shown to regulate migration and invasion (Chakraborty et al.,
2002).  Locally produced SDF-1α may have a similar in the low oxygen
environment of the chorionic villous stroma.  SDF-1α is a highly potent and
efficacious mononuclear cell attractant, inducing migration of many
hematopoietic cells, including monocytes (Bleul et al., 1996) and CD34+ stem
cells (Mohle et al., 1998; Voermans et al., 1999; Jo et al., 2000).
In our model, conditioned media from both HTR and HPF significantly
stimulated HSPC migration.  The bicyclam peptidomimetic CXCR4 antagonist
AMD3100 is a commonly used inhibitor of SDF-1α - CXCR4 interactions (De
Clercq, 2003).  Inclusion of AMD3100 in migration assays had no effect on
HTR-CM stimulation of migration.  On the other hand, AMD3100 inhibited
HPF-CM induced HSPC migration.  These results demonstrate that SDF-1α
locally produced in the chorionic villi stroma can stimulate migration of HSPC.
90
Inhibition of CXCR4 did not completely abolish HSPC migration illustrating
that multiple migratory stimuli are present in the developing placenta.  In fact,
trophoblast cells appear to secrete a different chemotactic factor or factors.
Further investigations will be needed to determine all of the factor(s) involved
in stimulating HSPC migration in the human placenta.
In order to enter the tissue of interest, hematopoietic cells must not only
migrate but must also transgress the endothelium.  To examine whether
placental-derived factors had the capacity to stimulate HSPC transendothelial
migration an in vitro assay was employed.  A layer of endothelial cells (i.e.
HUVEC) was cultured to confluence on insert membranes, thereby creating a
cellular barrier separating HSPC from the chemotactic stimulus.  For cells to
be quantified, HSPC must first actively move through the endothelial cell
monolayer.  Stimulation of transendothelial migration was noted when HSPC
were cocultured with HPF. Twenty-four hour culture of HPF in either low
oxygen environment (1% or 8%) demonstrated no significant differences.  The
levels of HSPC transendothelial migration were similar to when exogenous
SDF-1α was used as a chemotactic stimulus and could be inhibited with
AMD3100.  As previously discussed for migration, other locally produced
factors are likely involved.  The results from this particular transendothelial
migration assay, while interesting, do not provide a clear picture of the
mechanisms involved.  For example, inclusion of multiple cell types in an
assay increases the number of variables.  It remains possible, that increased
HSPC transendothelial migration actually represents an effect of HPF cells on
the endothelial cell monolayer and not a direct interaction of these factors on
HSPC.  Nonetheless, inclusion of AMD3100 in the assay provides adequate
proof that SDF-1α acting on CXCR4+ HSPC does play a significant role.
5.11 HSPC Adhesion in the Placental Microenvironment
By bringing cells to the places where they are needed, migration is the
first step in creating a placental HSPC niche.  Once the appropriate cells are
in location, a mechanism should exist, which helps retain cells in this niche.
True enough, published data indicates that CXCR4 activation is important for
the retention of VEGFR-1+ “hemangiocytes” within the neovascular niche (Jin
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et al., 2006a).   SDF-1α - CXCR4 signalling is implicated as the principal axis
regulating migration, retention and mobilisation of HSC during steady-state
homeostasis and injury (Lapidot et al., 2005).
One of the monocyte markers examined with flow cytometry, CD11b, is
another designation given to the αM integrin.   Thus, the increased expression
of CD11b during HSPC culture in placental oxygen tensions suggested an
associated alteration in cellular adhesion.  Along these lines, the expression of
several integrin subunits was examined in our HSPC culture model utilising
flow cytometry.  The adhesive properties of integrins rely on the association of
the various α subunits with different β subunits.  Indeed, HSPC were shown to
express several important integrin subunits during culture in physiological
oxygen concentrations.  In this investigation, expression of αM and the
associated β2 subunit as well as α4 and β1 was specifically evaluated.
Differences were noted between HSPC cultured in either 1% or 8% oxygen
when the expression of αM and α4 was examined.  Once again, decreasing
oxygen concentration resulted in an increase in HSPC αM expression.
Conversely, the expression of the α4 subunit was highest when cells were
cultured in 8% O2.  Whether or not these alterations represent different
adhesive properties of HSPC in 1% oxygen versus 8% oxygen remains
unclear.  Nonetheless, the α4β1 expression has been shown to be important
during the homing of progenitor cells to sites of neovascularisation (Jin et al.,
2006b).  It would be extremely interesting to explore whether the different
physiological oxygen tensions have different effects on HSPC function during
blood vessel formation.
Besides homing HSC to their BM niche, SDF-1α can also act as a
“retention factor”, entrapping angio-competent cells at sites of vascular
development in the pre-metastatic niche (Kaplan et al., 2005) and during adult
neovascularisation (Grunewald et al., 2006).  In ambient oxygen, HSPC
adhesion was greatest when the coculture consisted of placental stroma cells.
When a similar assay was performed in low oxygen atmospheres, HSPC
adhesion to HPF was also greater than control adhesion levels.  Again,
significant differences were not seen between the two oxygen concentrations
(1% and 8% O2).  Another interesting result obtained showed significant
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increases in HSPC adhesion to trophoblast (HTR) when the assay was
performed in physiologically relevant oxygen concentrations.  In this case,
HSPC adhesion to HTR was greatest in 1% oxygen reaching levels similar to
HSPC-HPF adhesion.  In the human placenta, locally derived SDF-1α also
appears to act as a retention factor due to the fact that including the CXCR4
antagonist AMD3100 in the experiment inhibited in vitro adhesion of HSPC to
placental stromal cells.  On the contrary, completely different mechanisms
appear to be at play in the adhesion of HSPC to trophoblast; these
mechanisms remain unclear, but may be dependent on oxygen concentration.
This assay provides interesting results regarding cell-cell interactions at a
specific point of time.  They do not, however, clarify whether this adhesion
represents a static condition or part of the dynamic process of HSPC
migration.  The latter now seems more probable.  Recent live-cell imaging
experiments have shown that HSPC adhesion to placental stromal cells in
vitro is a dynamic process with a great number of adhesive cells being
constantly in a migratory state (data not shown).  At the same time, formation
of HSPC colonies also appears to take place.  Further experimentation should
determine which microenvironmental cues provide the signal for HSPC to stop
migrating and colonise the placental HSPC niche.
5.12 Study Limitations
Although this investigation provides interesting data regarding the
impact of local oxygen tensions on formation of a placental HSPC niche, an
important point should be noted.  This qualification concerns the stem /
progenitor cells isolated, utilised and reported above.  CD133+ HSPC were
isolated from term UCB.  Isolation of HSPC at this particular time point (i.e.
term) results in the culture of, so-called, adult stem cells.  These cells are
definitive hematopoietic cells by nature.  In contrast, the earliest stages of
placental development occur during a point of time before definitive
hematopoiesis is fully established.  Studies into the earliest stages of human
development are fraught with a variety of difficulties - the most important being
the relative scarcity of healthy material.  The collection of early human tissue
normally involves samples obtained from elective terminations of pregnancies.
93
Compounded by the fact that most pregnancies are not discovered until after
some time has passed (∼1 month), collection of material representing the
earliest stages of pregnancy (i.e. ≤1 month) is rare.  The material obtained is
also small, adding further difficulties to such investigations.  Therefore, it was
deemed necessary that adult HSPC should be used during experimentation
as a general model for hematopoietic stem cells.
5.13 Perspectives
This report attempts to shed light on the cellular mechanisms involved
in the establishment of the placental stem cell niche and the involvement of
progenitor cells in placental blood vessel formation.  Further studies will be
needed before a full understanding of these early developmental events is
reached.  One focus for the future should be to elucidate the precise role that
HSPC play during vascular development.  A wide variety of angiogenesis
assays presently exist (e.g. network forming assay, spheroid formation,
sprouting assays).  Inclusion of HSPC in such assays in conditions mimicking
the in vitro placental microenvironment would be an interesting way to
examine whether HSPC contain intrinsic hemangioblastic potential.  However,
the suggestion that HSPC contain a hemangioblast population has not been
adequately explored.  On the other hand, present experiments suggest that
HSPC may have more of an accessory role during in vitro vessel formation.
Yet another interesting avenue for research concerns SDF-1α.  We
have shown that SDF-1α is one of the factors present in the developing
placenta and that SDF-1α regulates HSPC functions in this niche.
Nonetheless, in our model the intracellular mechanisms induced by SDF-1α
binding to CXCR4 remain unclear.  Moreover, the molecular events leading to
SDF-1α expression in placental stromal cells was also beyond the scope of
this study.  Future investigations should attempt to clarify the precise
molecular mechanisms regulating SDF-1α expression in developing chorionic
villi, as well as, explore signalling events stimulated by chemokine binding to
CXCR4+ HSPC.
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It is interesting to speculate about what other locally derived factors
regulate HSPC functions in the placenta.  This is a daunting task as the
placenta is home to a myriad of growth factors, hormones, and cytokines.
Nevertheless, such investigations could be accomplished using the
techniques described here.  Our novel in vitro model could be used in the
future to clarify specific molecular and cellular mechanisms involved during
formation of a placental stem cell niche, as well as, the involvement of stem /
progenitor cells during placental vascular development.
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6 CONCLUSIONS
Scientific investigations should make a clear distinction between true
hypoxia and physiologically low oxygen concentrations actually representing
normoxia.  For example, normoxia in the placental stem cell niche is
characterised by low oxygen.  We provide a novel model allowing for effective
simulation and monitoring of physiologically low oxygen levels in vitro.
Results from this investigation illustrate the involvement of the local oxygen
environment during creation of this HSPC niche.
Using HSPC isolated from UCB, we have demonstrated that
physiologically low oxygen plays a definite role in cell culture dynamics,
maintenance of stem cell characteristics, as well as in the induction of
differentiation.  We have shown that low oxygen culture in either 1% or 8% O2
significantly and dose-dependently decreased HSPC culture expansion,
rapidly increased the number of G0/G1 cells, and stimulated expression of
monocyte markers.
The low oxygen microenvironment of early chorionic villi is also a rich
source of placental-derived hormones, growth factors and chemokines.  Such
factors can be involved during hematopoietic and vascular cell development.
In the developing placenta, the chemokine SDF-1α appears to play an
important role (Figure 30).  Locally derived SDF-1α, produced in the chorionic
villous stroma, acts as a “homing” factor inducing migration of HSPC
expressing the specific SDF-1α receptor (CXCR4) to areas of vascular
development.  In this investigation, the direct involvement of SDF-1α during
stimulation of HSPC migration, transendothelial migration and cell-cell
adhesion was shown.  Blocking SDF-1α interactions with CXCR4 using
AMD3100 inhibited the placental stroma cell induction of cellular motility and
adhesion.  Trophoblast, as a major component of the developing placenta
also appears to play a role in the promotion of placental vasculogenesis.  A
direct link between hematopoietic cells and formation of the placental vascular
tree has yet to be proven.  However, the close developmental and spatial
proximity of HSPC and early vasculogenic cells, once again, suggests a
connection between their development.
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An important goal for future investigations should be to clarify the
precise mechanisms involved in placental formation, including growth of the
extensive placental vascular system.  Only with a better understanding of
healthy placental development will it be possible to understand the factors at
play during placental malformation and disease.
A. 
Chorionic
villous
Intervillous space
Syncytiotrophoblast
Villous Cytotrophoblast
Villous Stroma
Maternal Blood
O2
B. 
SDF-1α
HPFMMPs
HTR
HSPC
?
? ?
?
STB
EC
CXCR4
Figure 30. SDF-1α in the chorionic villous microenvironment.
Early placental vasculogenesis commences before chorionic villi
become bathed in maternal blood (A). HSPC are found in the
placental blood supply and villous stroma.  Syncytiotrophoblast
(STB) and villous trophoblast (HTR) surround the villous stroma.
Box at lower left magnified in (B). SDF-1α produced by chorionic
villous stromal cells (HPF) is secreted into the microenvironment.
Attracted by local SDF-1α, CXCR4+ HSPC invade the villous
stroma. HSPC involvement during placental vasculogenesis and/or
angiogenesis is unclear.  Secreted factors, such as active MMP
may play a role. Likewise, the involvement of trophoblast in this
model remains an interesting topic for investigation.
97
7 ZUSAMMENFASSUNG
Eine physiologische Entwicklung des Gefäßsystems der Plazenta und
dessen uneingeschränkte Funktion erlauben einen adäquaten Gasaustausch
sowie den Transport von Nährstoffen zwischen der Mutter und dem Fetus und
sind somit für eine normale embryonale Entwicklung von entscheidender
Bedeutung.  In der sich entwickelnden humanen Plazenta ist ein geringer
Sauerstoffpartialdruck physiologisch und für eine korrekte Entwicklung dieses
Organs von massgeblicher Bedeutung.
Im Rahmen der vorliegenden Studie konnte erstmalig ein Modell
entwickelt werden, was die Simulation dieser sauerstoffarmen Umgebung in
der Plazenta und die Messung von in vitro herrschenden
Sauerstoffpartialdrücken ermöglicht.  Mit seiner Hilfe wurde der Einfluss der
Sauerstoffkonzentration auf die Etablierung der plazentaren Nische für fetale
Stammzellen (HSPC) untersucht.  Insbesondere wurde die Proliferation,
Erhaltung ihres Stammzellphänotyps und Induktion ihrer Differenzierung
angesehen.  Dabei konnte gezeigt werden, dass die niedrige O2
Konzentration die Proliferation von HSPC hemmt, zum Anstieg von G0/G1
Zahl führt und die Induktion von monozytären Markern verursacht.
In der reduzierten O2-Atmosphäre der frühen Plazenta wird zusätzlich
eine Vielzahl von Wachstumsfaktoren, Hormonen und Chemokinen
produziert, die in hämatopoetischen sowie in vaskulo- und angiogenetischen
Vorgängen eine wichtige Rolle spielen.  Im hier etablierten Modell wurde die
Wirkung des Chemokins SDF-1α, das von plazentaren Stromazellen
produziert wird, auf CXCR4 (Rezeptor für SDF1) positive HSPC hinsichtlich
Migration, transendotheliale Migration und Adhäsion in der plazentaren
Nische untersucht.  Es konnte gezeigt werden, dass das durch die plazentare
Stromazellen produzierte SDF-1α sowohl die Migration und die
transendotheliale Migration als auch die Adhäsion von HPSC stimuliert.  Im
Gegensatz dazu führte die Zugabe von entsprechenden neutralisierenden
Substanzen (AMD3100) zur einer signifikanten Reduktion der zellulären
Adhäsion und Mobilität.
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Ein wichtiges Ziel für weitere Untersuchungen sollte es sein, die
genauen Mechanismen, die der Plazentabildung und Entstehung des
weitverzweigten plazentaren Gefässbaumes zugrundeliegen, aufzudecken.
Denn nur durch das Verständnis der physiologischen Plazentaentwicklung ist
es möglich, die krankhaften Veränderungen dieses Organes zu verstehen.
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